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Abstract 
This study concentrates on the identification and quantification of three pharmaceutical 
compounds (ibuprofen, naproxen and diclofenac) and an endocrine disrupting compound (17α-
ethinylestradiol) in wastewater effluents collected from Adelaide Wastewater Treatment Plant 
and Greenway Pollution Control Plant, London, ON, Canada.  For sample preparation, both 
solid-phase extraction and liquid-liquid extraction techniques were followed and GC-FID and 
LC-MS were used for sample analysis. Although the target pharmaceuticals were present in the 
wastewater samples at concentrations in a range of 0.29-8.98 µ/L, 17α-ethinylestradiol was not 
detected. 
For eradicating or removing the above-mentioned organic compounds from water, 
organic solvent nanofiltration (OSNF) membrane was used in this study. Different types of 
OSNF membranes were prepared where commercially available PTFE ultrafiltration 
membrane as well as laboratory-made polysulfone ultrafiltration membranes served as the base 
supports, and poly (dimethylsiloxane) as the thin active layer. A thin film composite membrane 
was also prepared using a base support made of a mixture of polysulfone and multi-walled 
carbon nanotubes and a thin active layer top constituted from interfacial polymerization 
between m-phenylenediamine and trymesoyl chloride. For membrane characterization, 
Scanning Electron Microscopy (SEM) and Atomic Force Microscoopy (AFM) were 
performed. The performance of the membranes was studied by monitoring permeability along 
with the removal capacity using a dead-end filtration system, under a pressure range of 5~30 
bars. A commercially available polyimide membrane, DuraMem, was exploited to compare the 
membrane performance. The 2.5% PTFE/PDMS (RTV 615) membrane showed the highest 
performance by removing 95~97% 17α- ethinylestradiol, 70% ibuprofen, 65% naproxen and 
65% diclofenac. Hansen’s Solubility Parameter theory was adopted to explain the removal 
mechanism of pharmaceutical compounds, while size exclusion theory explained the removal 
of the synthetic estrogen by OSNF. 
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Chapter 1 
1 Introduction 
The incidence of emerging or recently recognized pollutants in our water resources 
is of great concern to the health and safety of the consuming public. These contaminants 
are defined as low molecular weight, synthetic or naturally occurring compounds, not 
commonly monitored in the environment. Wastewater effluents from municipal treatment 
plants [1, 2], hospital effluents [3, 4], industrial as well as livestock wastewater [5]  are 
common sources of trace contaminants in the environment; they are present usually in the 
µg/L range or less. Most trace contaminants are anthropogenic, created in extensive 
quantities for many purposes, for example, as pharmaceuticals, pesticides, refrigerants, dye 
carriers, propellants, pigments, dielectric fluids, preservatives, heat transfer media, 
degreasers & lubricants [6]. Along with contributing to the prosperity of the world and 
preventing many diseases, these synthetic organic compounds create an environmental 
menace due to a combination of physiochemical and toxicological properties [6]. Being 
continuously introduced in the environment along with their presence at small 
concentrations may cause potential negative impact on drinking water supplies, human 
health and ecosystem behavior [7, 8]. Furthermore, this may also result in the introduction 
of by-products and metabolites of these chemicals into the environment, creating even 
more damaging conditions than the parent compounds [6]. Dispersion, aggregation and 
volatility are the major characteristics of the trace contaminants leading to a further division 
into different groups covering pesticides, pharmaceutically active compounds, persistent 
organic compounds and endocrine disrupting chemicals [9]. A particular attention has been 
paid to pharmaceuticals and endocrine disrupting compounds since they may function at 
very low concentrations (ng/L range) [10]. 
Pharmaceutical compounds along with their metabolites are publicly denoted as 
pharmaceutically active compounds (PhACs) [11]. According to Bush [12], the most 
commonly detected pharmaceuticals in water are anti-inflammatories and analgesics 
(acetylsalicylic acid, ibuprofen, diclofenac and paracetamol); antidepressants 
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(benzodiazepines); antiepileptic (carbamazepine); lipid-lowering drugs (fibrates); β-
blockers (atenolol, metoprolol and propranolol); antiulcer drugs and antihistamines 
(famotidine and ranitidine); antibiotics (β-lactams, chloramphenicol, fluoroquinolones, 
imidazole derivatives macrolides, penicillin, quinolones, sulfonamides and tetracyclines) 
and other substances (amphetamines, barbiturates, cocaine, methadone and other 
narcotics). Pharmaceuticals like cyclophosphamide, erythromycin, naproxen and 
sulfamethoxazole can persist in the environment for a year whereas clofibric acid lingers 
on for several years, being biologically active through accretion [8]. According to some 
researchers, it is currently not clear whether the presence of PhACs through exposure to 
multiple compounds at a very low levels could invoke an increased toxic or synergistic 
effects [13]; however, [14] validated that a mixture of pharmaceuticals at ng/L range can 
lead to physiological and morphological effects on human embryonic cells. Moreover, the 
catastrophic consequences on the population of vultures in India and Pakistan due to the 
use of the anti-inflammatory drug, diclofenac [15], has made the researchers to extend their 
studies and analysis regarding the effects of PhACs in aquatic environment. The target 
PhACs selected for this study are ibuprofen (IBP), naproxen (NPR) and diclofenac (DCF). 
These are known as nonsteroidal anti-inflammatory drugs (NSAIDs) widely used over the 
world and possess analgesic and antipyretic activities.  
Endocrine disrupting compounds (EDCs) are another major group of emerging 
pollutants with estrogenic/ androgenic action, comprised of a wide band of compounds 
with multifaceted roles that are dissimilar in their forms [9, 16-22]. EDCs are highlighted 
for impeding the reproductive systems of wildlife and humans through imitating the 
biological activity of natural hormones, subjugating the hormone receptors, or restricting 
the transport and metabolic processes of natural hormones [23]. Although EDCs exist at 
very low concentrations in the aquatic environment, they pose a threat to water quality and 
are believed to lessen fertility and intensify the manifestation of breast, ovarian and tubular 
cancer [9, 24]. Natural estrogens, such as estron (E1); 17β-estradiol (E2) and estriol (E3); 
natural androgens, such as testosterone (T), dihydrotestosterone (DHT) and androsterone 
(A); artificial synthetic estrogens or androgens, such as 17α-ethinylestradiol (EE2), 
norgestrel (N) and trenbolone (Tr); phytoestrogens as well as other industrial compounds 
like bisphenol A, nonyphenol etc. comprise the broad class of EDCs [17]. Among all of 
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these EDCs, EE2 has been selected for this study because it possibly demonstrates the 
sturdiest estrogenic effect, about ten times higher than that of natural hormones, interferes 
with the development of living organisms and should be considered as the EDC of the 
greatest concern [6, 25-27]. 
Very few protections and monitoring guidelines for EE2 and pharmaceuticals have 
been proposed so far; the identification of EE2 is rather complex due to the absence of 
strict protocols specific to EE2 [28]. Consequently, the evolution of low-cost technique for 
recognition of PhACs and EDCs, especially for EE2 and its estrogenic activity in 
wastewater is still an emergent and thought-provoking research area [17, 28]. Since 
existing conventional wastewater treatment plants (e.g., activated sludge) have not been 
demonstrated to effectively remove this estrogen, enhanced, innovative and highly 
sensitive analytical and bio-analytical technologies are needed to detect their low 
concentration in complex matrices such as wastewater [17, 28]. Under these circumstances, 
nanofiltration (NF) and reverse osmosis (RO) membrane techniques have become more 
prevalent and are receiving increasing attention because of their supreme performance in 
removing micro-pollutants from waste water [17, 28-30]. Having pore sizes between 0.2 
and 0.4 nm [28, 31], the NF membrane can remove most trace micro pollutants [6, 17, 22, 
32-34]. The low operating pressure (10-50 bar), high flux rate, high retention of multivalent 
anions, relatively low investment, low operating and maintenance costs and environmental 
friendliness along with delivering high quality effluent demonstrate NF as an attractive 
option for treatment of organic contaminants.  
On the other hand, Organic Solvent Nanofiltration (OSNF), one of the most recent 
membrane techniques, has been known to have very high potential to escalate the 
concentration of dilute species from low molecular weight solvents [35]. This technique 
affords the recycling of organic solvents at lower energy when paralleled to conventional 
processes [35, 36]. Molecules of 200-1,000 g/mol in several organic solvents have been 
successfully separated using OSNF membranes [37]. Most OSNF membranes are 
asymmetric and integrally skinned, they might be free-standing and made of polyimides 
(PI) or composites with a thin active layer on a porous support. Recently the potential for 
using polydimethylsiloxane (PDMS) has been verified in cases of nanofiltration, 
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pervaporation and vapor permeation [38]. It has been suggested that the highly 
hydrophobic PDMS can be utilized for the preparation of OSNF membranes with high flux, 
high selectivity and excellent removal capacity of most organics [39]. A free standing 
PDMS membrane is much thicker when matched to the active layer of the thin film 
composite membranes. Therefore, composite PDMS membranes, with a selective, defect-
free membrane film of sub-micrometer size thickness over a porous support could serve 
better in terms of permeability. The PDMS composite membranes on a variety of porous 
supports, like polysulfone, polyethersulfone, polyetherimides, polyimides, 
polyacrylonitriles, polyesters, ceramics etc., have been described in a number of scientific 
studies [40]. Stafie et al. [41] used polyacrylonitrile/PDMS (PAN/PDMS) composite 
membranes for separation of hexane from mixtures of oil/ hexane and PIB-hexane. Dutczak 
et al. [37] manufactured composite capillary PDMS membranes to determine the 
permeance of toluene, whereas Vankelekom et al. [42] made a polyacrylonitrile-
polyester/PDMS (PAN-PE/PDMS) composite membrane for the same purpose.  
1.1 Scope and Objectives 
To the best of our knowledge, OSNF membranes have only been used, so far, in 
gas permeation and pervaporation; they have not yet been utilized in removing trace 
organic components from water. The scope of the present work is to prepare, characterize 
and evaluate the efficiency of a custom made PDMS membrane for the removal of PhACs 
and EE2. However, it was important to first evaluate the presence of the PhACs and EE2 
in the wastewater effluents in the study area (London, ON, Canada). Thus, the first part of 
this research work covers the testing of wastewater effluents collected from different 
wastewater treatment plants in London, ON to identify and quantify the presence of the 
specific compounds. For analytical determination and quantification, sensitive analytical 
methods based on enrichment steps, chromatographic separation and necessary 
derivatization were investigated.  
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The specific objectives of the study were to: 
 Identify and quantify the presence of selected PhACs (ibuprofen, naproxen, and 
diclofenac) and 17α-ethinylestradiol in the effluents from Wastewater Treatment 
Plants (WWTPs) in London, Ontario, Canada.  
 Prepare a customized PDMS Composite Nanofiltration Membrane, and evaluate its 
efficiency in removing ibuprofen, naproxen, diclofenac and 17α-ethinylestradiol 
from water. 
 Compare the characteristics and efficiency of the PDMS membrane with a Thin 
Film Composite (TFC) membrane and a commercially available OSNF membrane. 
1.2 Outline of the thesis 
The thesis consists of the following five chapters: 
 Chapter 1 gives a brief introduction of the research work along with the scope and 
objectives. 
 
 Chapter 2 provides a review of pertinent literature to highlight several aspects of 
research conducted on the presence of pharmaceuticals and EE2 in the aquatic 
environment, different methodologies used to synthesize thin film composite and 
organic solvent nanofiltration membranes along with their performance criteria. 
 
 Chapter 3 discusses the materials and methodologies used in the study, including 
collection of wastewater samples; preparation of samples for analytical 
investigation, such as solid-phase extraction, liquid-liquid extraction and 
derivatization; development of necessary analytical methods to run samples on 
liquid chromatography/mass spectrometry and gas chromatography/flame 
ionization detector; preparation of different kinds of OSNF and TFC membranes 
along with characterization and permeability performance evaluation. 
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 Chapter 4 presents and discusses the results obtained from the experiments. 
 
 Chapter 5 is the concluding chapter; it provides a summary of the whole work with 
further recommendations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
1.3 References 
[1] D.W. Kolpin, E.T. Furlong, M.T. Meyer, E.M. Thurman, S.D. Zaugg, L.B. Barber, H.T. 
Buxton, Pharmaceuticals, hormones, and other organic wastewater contaminants in US 
streams, 1999-2000: A national reconnaissance, Environmental science & technology, 36 
(2002) 1202-1211. 
[2] Y. Filali-Meknassi, R. Tyagi, R. Surampalli, C. Barata, M. Riva, Endocrine-disrupting 
compounds in wastewater, sludge-treatment processes, and receiving waters: Overview, 
Practice Periodical of Hazardous, Toxic, and Radioactive Waste Management, 8 (2004) 
39-56. 
[3] K. Kümmerer, Drugs in the environment: emission of drugs, diagnostic aids and 
disinfectants into wastewater by hospitals in relation to other sources–a review, 
Chemosphere, 45 (2001) 957-969. 
[4] P. Verlicchi, A. Galletti, M. Petrovic, D. Barceló, Hospital effluents as a source of 
emerging pollutants: an overview of micropollutants and sustainable treatment options, 
Journal of Hydrology, 389 (2010) 416-428. 
[5] L.S. Shore, M. Shemesh, Naturally produced steroid hormones and their release into 
the environment, Pure and Applied Chemistry, 75 (2003) 1859-1871. 
[6] Y. Koh, T. Chiu, A. Boobis, E. Cartmell, M. Scrimshaw, J. Lester, Treatment and 
removal strategies for estrogens from wastewater, Environmental Technology, 29 (2008) 
245-267. 
[7] I. Sirés, E. Brillas, Remediation of water pollution caused by pharmaceutical residues 
based on electrochemical separation and degradation technologies: a review, Environment 
international, 40 (2012) 212-229. 
[8] J. Rivera-Utrilla, M. Sánchez-Polo, M.Á. Ferro-García, G. Prados-Joya, R. Ocampo-
Pérez, Pharmaceuticals as emerging contaminants and their removal from water. A review, 
Chemosphere, 93 (2013) 1268-1287. 
8 
 
[9] L. Nghiem, A. Manis, K. Soldenhoff, A. Schäfer, Estrogenic hormone removal from 
wastewater using NF/RO membranes, Journal of Membrane Science, 242 (2004) 37-45. 
[10] E. Vulliet, C. Cren-Olivé, M.-F. Grenier-Loustalot, Occurrence of pharmaceuticals 
and hormones in drinking water treated from surface waters, Environmental Chemistry 
Letters, 9 (2011) 103-114. 
[11] C.G. Daughton, Pharmaceutical ingredients in drinking water: overview of occurrence 
and significance of human exposure, in:  ACS symposium series, Oxford University Press, 
2010, pp. 9-68. 
[12] K. Bush, Antimicrobial agents, Current opinion in chemical biology, 1 (1997) 169-
175. 
[13] P.E. Stackelberg, E.T. Furlong, M.T. Meyer, S.D. Zaugg, A.K. Henderson, D.B. 
Reissman, Persistence of pharmaceutical compounds and other organic wastewater 
contaminants in a conventional drinking-water-treatment plant, Science of the total 
environment, 329 (2004) 99-113. 
[14] F. Pomati, S. Castiglioni, E. Zuccato, R. Fanelli, D. Vigetti, C. Rossetti, D. Calamari, 
Effects of a complex mixture of therapeutic drugs at environmental levels on human 
embryonic cells, Environmental Science & Technology, 40 (2006) 2442-2447. 
[15] J.L. Oaks, M. Gilbert, M.Z. Virani, R.T. Watson, C.U. Meteyer, B.A. Rideout, H. 
Shivaprasad, S. Ahmed, M.J.I. Chaudhry, M. Arshad, Diclofenac residues as the cause of 
vulture population decline in Pakistan, Nature, 427 (2004) 630-633. 
[16] L. Braeken, B. Van der Bruggen, Feasibility of nanofiltration for the removal of 
endocrine disrupting compounds, Desalination, 240 (2009) 127-131. 
[17] Z.-h. Liu, Y. Kanjo, S. Mizutani, Removal mechanisms for endocrine disrupting 
compounds (EDCs) in wastewater treatment—physical means, biodegradation, and 
chemical advanced oxidation: a review, Science of the Total Environment, 407 (2009) 731-
748. 
9 
 
[18] P. Mazellier, L. Méité, J. De Laat, Photodegradation of the steroid hormones 17β-
estradiol (E2) and 17α-ethinylestradiol (EE2) in dilute aqueous solution, Chemosphere, 73 
(2008) 1216-1223. 
[19] P.A. Neale, B.I. Escher, A.I. Schäfer, pH dependence of steroid hormone—organic 
matter interactions at environmental concentrations, Science of the Total Environment, 407 
(2009) 1164-1173. 
[20] J.-Y. Pailler, A. Krein, L. Pfister, L. Hoffmann, C. Guignard, Solid phase extraction 
coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, 
tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg, 
Science of the Total Environment, 407 (2009) 4736-4743. 
[21] E.J. Rosenfeldt, K.G. Linden, Degradation of endocrine disrupting chemicals 
bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation 
processes, Environmental Science & Technology, 38 (2004) 5476-5483. 
[22] A. Schäfer, L. Nghiem, T. Waite, Removal of the natural hormone estrone from 
aqueous solutions using nanofiltration and reverse osmosis, Environmental Science & 
Technology, 37 (2003) 182-188. 
[23] B. Pan, D. Lin, H. Mashayekhi, B. Xing, Adsorption and hysteresis of bisphenol A 
and 17α-ethinyl estradiol on carbon nanomaterials, Environmental science & technology, 
42 (2008) 5480-5485. 
[24] L. Joseph, J. Heo, Y.-G. Park, J.R. Flora, Y. Yoon, Adsorption of bisphenol A and 
17α-ethinyl estradiol on single walled carbon nanotubes from seawater and brackish water, 
Desalination, 281 (2011) 68-74. 
[25] L. Clouzot, P. Doumenq, P. Vanloot, N. Roche, B. Marrot, Membrane bioreactors for 
17α-ethinylestradiol removal, Journal of Membrane Science, 362 (2010) 81-85. 
[26] D.L. Lima, R.J. Schneider, V.I. Esteves, Sorption behavior of EE2 on soils subjected 
to different long-term organic amendments, Science of the total environment, 423 (2012) 
120-124. 
10 
 
[27] J.L. Parrott, B.R. Blunt, Life‐cycle exposure of fathead minnows (Pimephales 
promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization 
success and demasculinizes males, Environmental toxicology, 20 (2005) 131-141. 
[28] N. Bolong, A. Ismail, M.R. Salim, T. Matsuura, A review of the effects of emerging 
contaminants in wastewater and options for their removal, Desalination, 239 (2009) 229-
246. 
[29] Y. Yoon, P. Westerhoff, S.A. Snyder, E.C. Wert, J. Yoon, Removal of endocrine 
disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration 
membranes, Desalination, 202 (2007) 16-23. 
[30] Y. Yoon, P. Westerhoff, J. Yoon, S.A. Snyder, Removal of 17β estradiol and 
fluoranthene by nanofiltration and ultrafiltration, Journal of Environmental Engineering, 
130 (2004) 1460-1467. 
[31] B. Nowack, The behavior and effects of nanoparticles in the environment, 
Environmental Pollution, 157 (2009) 1063-1064. 
[32] M. Bodzek, M. Dudziak, Elimination of steroidal sex hormones by conventional water 
treatment and membrane processes, Desalination, 198 (2006) 24-32. 
[33] A. Deegan, B. Shaik, K. Nolan, K. Urell, M. Oelgemöller, J. Tobin, A. Morrissey, 
Treatment options for wastewater effluents from pharmaceutical companies, International 
Journal of Environmental Science & Technology, 8 (2011) 649-666. 
[34] L. Nghiem, A. Schäfer, T. Waite, Adsorptive interactions between membranes and 
trace contaminants, Desalination, 147 (2002) 269-274. 
[35] H.B. Soltane, D. Roizard, E. Favre, Study of the rejection of various solutes in OSN 
by a composite polydimethylsiloxane membrane: Investigation of the role of solute 
affinity, Separation and Purification Technology, 161 (2016) 193-201. 
[36] S. Darvishmanesh, J. Vanneste, E. Tocci, J.C. Jansen, F. Tasselli, J. Degrève, E. Drioli, 
B. Van der Bruggen, Physicochemical characterization of solute retention in solvent 
11 
 
resistant nanofiltration: the effect of solute size, polarity, dipole moment, and solubility 
parameter, The Journal of Physical Chemistry B, 115 (2011) 14507-14517. 
[37] S. Dutczak, M. Luiten-Olieman, H. Zwijnenberg, L. Bolhuis-Versteeg, L. Winnubst, 
M. Hempenius, N. Benes, M. Wessling, D. Stamatialis, Composite capillary membrane for 
solvent resistant nanofiltration, Journal of Membrane Science, 372 (2011) 182-190. 
[38] J.P. Robinson, E.S. Tarleton, K. Ebert, C.R. Millington, A. Nijmeijer, Influence of 
cross-linking and process parameters on the separation performance of poly 
(dimethylsiloxane) nanofiltration membranes, Industrial & engineering chemistry 
research, 44 (2005) 3238-3248. 
[39] M. Bennett, B. Brisdon, R. England, R. Field, Performance of PDMS and 
organofunctionalised PDMS membranes for the pervaporative recovery of organics from 
aqueous streams, Journal of Membrane Science, 137 (1997) 63-88. 
[40] L. Li, Z. Xiao, S. Tan, L. Pu, Z. Zhang, Composite PDMS membrane with high flux 
for the separation of organics from water by pervaporation, Journal of Membrane Science, 
243 (2004) 177-187. 
[41] N. Stafie, D. Stamatialis, M. Wessling, Insight into the transport of hexane–solute 
systems through tailor-made composite membranes, Journal of Membrane Science, 228 
(2004) 103-116. 
[42] I.F. Vankelecom, K. De Smet, L.E. Gevers, A. Livingston, D. Nair, S. Aerts, S. 
Kuypers, P.A. Jacobs, Physico-chemical interpretation of the SRNF transport mechanism 
for solvents through dense silicone membranes, Journal of membrane science, 231 (2004) 
99-108. 
 
 
 
12 
 
Chapter 2 
2 Literature Review 
The removal of pharmaceuticals and endocrine disrupting compounds through the 
municipal wastewater treatment plants have been found to be neglected [1-6] resulting in 
~80% of the total load of these active compounds being discharged into surface waters [7]. 
This chapter reviews the literature regarding the occurrence of pharmaceuticals and 
estrogenous compounds in the aquatic environment, their conventional removal 
technologies, nanofiltration and the methods of preparation and performance of different 
types of nanofiltration membranes. 
2.1 Occurrence of 17α-ethinylestradiol (EE2) in the aquatic 
environment and its removal 
17α-ethinylestradiol (EE2) is used in almost all modern formulations of combined 
oral contraceptive pills, medicines for the (i) menopausal and postmenopausal syndrome, 
(ii) physiological replacement therapy in deficiency states, (iii) treatment of prostatic 
cancer and breast cancer in postmenopausal women, and (iv) osteoporosis, and other 
ailments [8-10]. In the hormonal birth control, it is usually present in the form of a 
combination medication including a form of progesterone or progestin. EE2 is a nonpolar 
and hydrophobic organic compound with low volatility and is resilient to biodegradation 
[11]. It is a derivative of 17β-estradiol (E2) and is defined by an aromatic ring with 
hydroxyl group at the C-3 and an ethinyl group at C-17 (Figure 2.1); this ethinyl group is 
responsible for its resistance to biodegradation unlike other endogenous estrogens [12]. 
Therefore, EE2 has a longer persistence in the environment with a dissipation time in the 
order of 20~40 days in the river system as a result of its lowest biodegradation efficiency 
as well as insufficient removal in wastewater treatment plants [12, 13]. The physiochemical 
characteristics of the molecule are summarized in Table 2.1 
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Figure: 2.1 – Chemical Structure of 17α-Ethinylestradiol (EE2)  
 
Table 2.1: Physiochemical Properties of EE2 [12, 14, 15] 
Chemical Formula C20H24O2 
Molecular weight (g/mol) 296.4 
Molecular width (Ao) 5.7 
Molecular length (Ao) 11.9 
Molecular volume (Ao3) 881.1 
Dipole moment (µD) 2.64 
Water Solubility (mg/L) 4.8 
Log KOW 3.67 
Vapor Pressure (mm Hg) 6 x 10-9 
Henry’s Law constant (atm-m3/mole) 7.94 x 10-12 
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While EDCs move in the environment from innumerable disseminated points, 
several researchers have shown that the most likely source of EDCs in the aquatic 
environment is the discharge of municipal and/or industrial effluents along with the runoff 
from agricultural production and irrigation return waters, such as pesticides and animal 
husbandry hormones and medicines [1, 16, 17]. It has been detected that the release of large 
amounts of expired medicines from households as well as in waste from hospitals and 
pharmaceutical companies upsurge the concentration EE2 along with mestranol and 
diethylstilbestrol in the environment [14]. A substantial part of the endogenous estrogens 
is emitted from human and animal bodies through urine as glucuronides and sulfates 
complexes; thus, occurs their presence in municipal wastewater [1, 14, 18]. Nevertheless, 
these can be quickly cleaved and metabolized into an active form or parent compound due 
to microbial deconjugation in the course of transport and treatment in a Water Treatment 
Plant resulting at concentrations up to sub nanograms per liter levels [1, 19, 20]. EDCs’ 
presence and main distribution in the environment is illustrated in Figure 2.2. 
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Figure 2.2: EDCs’ distribution in the environment [21, 22] 
In human body, EE2 has revealed one to two times higher binding affinity to the 
estrogen receptor (ER) than E2, whereas up to five times higher binding affinity in some 
fish species [23]. When compared to naturally produced E2, the higher receptor affinity 
designates EE2 as a more potent estrogenic compound, even though at extremely low 
(ng/L) concentrations, in case of stimulating an estrogenic response [19, 24-27]. 
Researchers have found that 50 ng/L E1, 54 ng/L E2 and 21.7 µg/L E3 are responsible for 
sex change in fish whereas only 6 ng/L of EE2 is adequate enough for 100% alteration of 
male fish into female [28] through the development of rare testes, making of an egg protein 
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precursor usually created in female fish, low circulation of sex hormone levels as well as 
dropping gonad size [29-31]. Concentrations of EE2<10 ng/L can completely shut down 
the egg production in fishes [32] and persuade vitellogenin (VTG) production in male 
zebrafish, Japanese medaka and rare minnow [33]. Even EE2 < 1 ng/L in water could have 
a clear contribution to the reproductive end point of fishes [32]. 
Because of the increased awareness of the risks involved with EE2, the removal of 
this synthetic estrogen from water and wastewater to levels that do not pose any health risk 
have been given considerable attention by public health officials. Traditional methods/ 
conventional wastewater treatments favorably remove more hydrophobic, larger molecular 
weight (MW) compounds leaving behind the more hydrophilic smaller compounds. One 
research study done in Europe revealed that a 14-hour hydraulic contact time with activated 
sludge removed approximately 85% of 17β-estradiol, estriol and mestranol whereas the 
removal of estron was even less [14]. In another research work, conventional treatment was 
able to remove about 60~70% of 17β-estradiol [34]. After assessing six waste water 
treatment plants (WWTPs) in Rome, Baronti et al. [35] found that an average removal of 
87% E2, 61% E1, 85% EE2 and 95% E3 was possible through activated sludge treatment. 
Again, a study on a number of WWTPs in Canada revealed that a full scale municipal 
wastewater treatment plant removed 74.9% EE2, 93.2% E1 and 83.3% E2 [36]. Although 
conventional treatment methods have been found to be quite effective in removing EDCs 
up to a certain extent from wastewater, researchers have noticed that a very low 
concentration of these chemicals in the downstream effluents is still a major concern [17].  
Furthermore, it has also been observed that the concentration of these micropollutants in 
the treated wastewater is often higher than that in the influent due to the transformation of 
biologically inactive conjugated estrogens into free forms by some enzymes present in a 
specific ecosystem [14].  Given the increasing difficulty in meeting maximum contaminant 
levels (MCLs), researchers are trying to recover the outmoded treatment methods. Several 
procedures including physical, chemical and biological treatment processes are being used 
to clean up wastewaters depending on the type and extent of contamination. Innovative, 
highly sensitive analytical and bio-analytical methodologies are continuously being 
investigated to detect the low concentration of these contaminants in complex matrices like 
wastewater [21, 22, 37, 38]. Photolysis, Ultra Violet (UV) irradiation, oxidation, 
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hydrolysis, and reverse osmosis are some of the physico-chemical transformation 
processes that EDCs undergo [39, 40]. Rapid filtration (88%), chlorination and 
coagulation/ sedimentation can remove 20~40% of E1, E2 and EE2 from drinking water 
[18]. On the other hand, activated carbon (AC) made from carbonaceous material such as 
wood, bark, coal, bone and solid petroleum residue is a relatively inexpensive material with 
an enormous surface area, typically 1, 000 m2/g and is mostly used to remove trace amounts 
of EDCs from water in the form of both powdered (5~100μm) and granular form 
(0.6~0.9mm) [22]. Irradiating water with UV light is another attractive alternative to 
chemical treatment methods. EDCs are more effectively degraded utilizing UV/H2O2 
(hydrogen per oxide) advanced oxidation in comparison to direct UV photolysis treatment 
[17]. Another strategy to remove EDCs can be the implementation of Manganese dioxide 
(MnO2) as an oxidative removal substrate. MnO2 is a well-known solid phase oxidant and 
can remove ~81.7% of EE2 due to its adsorption capacity and catalytic properties [1]. 
Besides, a further technique, Fenton’s oxidation, is cost effective, non-toxic and has 
homogenous catalytic nature [41]. Furthermore, several researchers have also used 
Titanium dioxide (TiO2) nanowires to treat water and wastewater [17]. However, even after 
these treatments, some compounds might continue to be present in drinking water due to 
their low biodegradability, high chemical stability, and high water solubility and reduced 
propensity for sorption. 
2.2 Pharmaceutically Active Compounds in aquatic 
environment and their removal 
Most of the pharmaceutical compounds possess a molecular mass less than 500 Da 
[42]; they are polar molecules with more than one ionization group and the degree of 
ionization and their characteristics are dependent on the pH of the medium [43].  
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Figure: 2.3 Chemical Structure of a) Ibuprofen b) Naproxen c) Diclofenac 
Table 2.2: Physiochemical Properties of Ibuprofen, Naproxen and Diclofenac 
 
 Ibuprofen Naproxen Diclofenac 
Chemical Formula C13H18O2 [44] C14H14O3 [44] C14H11NCl2O2 
[45] 
Molecular weight (g/mol) 206.30 [44] 230.3 [46] 296.2 [45] 
Water Solubility (mg/L) <1 [45] 15 [46] 2.37 [45] 
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pKa 4.91 [44] 4.15 [44] 4.15 [44] 
Log KoW 4.13-4.91 [44] 3.18-3.24  [44] 4.51 [44] 
Vapor Pressure (mm Hg) 1.86 X 10-4 [47] 1.89 X 10-6 
[48] 
6.14 X 10-8 [47] 
Henry’s Law constant (atm-
m3/mole) 
1.5 X 10-7 [44] 3.39 X 10-10 
[44] 
4.73 X 10-12[44] 
 
Figure 2.4 shows different possible pathways through which pharmaceuticals could 
enter water. Different types of pharmaceutical compounds can be disposed into the sewage 
system from different sources like hospitals, personal consumption, livestock, and 
aquafarming mainly in two ways: through inclusion in normal rubbish tips and via human 
or animal feces or urine. The sewage is then led through WWTPs and afterwards move into 
the water systems.  Here a wide selection of these compounds and their metabolites have 
been detected making compound and more complex mixtures exhibiting synergetic effects 
[49-52]. 
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Figure 2.4: Pharmaceuticals dissemination in the environment [43]  
As stated in recent research [53-57], some of the pharmaceuticals (e.g.- β-blockers, 
analgesics, antacids, antibiotics, antidepressants, antipyretics, lipid-lowering drugs, 
stimulants and tranquilizers) are not entirely removed by conventional WWTPs due to their 
complex molecular structure and/or low molecular weight [2, 50, 58] and thus have been 
detected in surface and ground water of different regions of the world. According to 
Carballa et al. [59] although some pharmaceuticals can be removed in primary treatments 
by adsorption; ibuprofen (IBP), naproxen (NPR), sulfamethoxazole and iopromide remain 
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in the water and subsequent biological treatment can eliminate only 30-70% of the anti-
inflammatories. Heberer [60] reported that WWTPs are not at all effective in removing 
diclofenac (DCF); at least five sub products are generated during chlorination of DCF and 
the degree of mineralization attained is significant [61]. Following the study of Petrovic et 
al [62], Table 2.3 summarizes the concentrations of some of the pharmaceutical compounds 
detected in wastewaters of various WWTPs before and after treatment. The variation in 
concentrations of the compounds before and after treatment confirms the inability of 
conventional WWTPs to completely remove a number of pharmaceutical compounds. The 
removal degree varies from 1 to 80%.  
Table 2.3: Detection of Pharmaceuticals in the Influent and Effluents of WWTPs [62] 
Compounds detected 
 
WWTPs 
influent (ng/L) 
WWTPs effluent 
(ng/L) 
% Removal 
Ketoprofen 451 318 29.49 
Naproxen 99 108 -9.09 
Ibuprofen 516 266 48.45 
Diclofenac 250 215 14.0 
Acetaminophen 10194 2102 79.38 
Bezafibrate 23 10 56.52 
Clofibrate 72 28 61.11 
Gemifibrozil 155 120 22.58 
Carbamazepine 420 410 2.38 
Ranitidine 188 135 28.19 
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Azithromycin 152 96 36.84 
Metronidazole 80 43 46.25 
Sulfamethoxazole 590 390 33.90 
Trimethoprim 1172 290 75.26 
Atenolol 400 395 1.25 
Sotalol 185 167 9.73 
Propanolol 290 168 42.07 
    
Conventional treatment methods have been found to be inefficient in the complete 
removal of pharmaceutical compounds from water [43]. Conventional Activated Sludge 
can remove ~45% IBP, ~0.1% NPR and ~35% DCF [43]. The degree of removal varies 
with different factors, such as type of treatment process, hydraulic retention times, solid 
retention times as well as the physicochemical properties of the compounds.  Since most 
of the PhACs are not degraded to the desired levels through biodegradation [43], research 
is being focused on the development of new technologies for the safe destruction of micro 
pollutants. Advanced oxidation processes (AOPs) have been found to be quite successful 
in removing refractory, toxic and organic pollutants that are not treatable by conventional 
technologies [43]. However, it is not clear if compounds are completely mineralized or not; 
intermediate products might cause possibly greater adverse effects on human and 
ecological system [63]. Moreover, the operational cost, when using hydrogen peroxide 
(H2O2) is a barrier. Heterogeneous photo catalysis is another procedure that has been 
utilized as a removal technology for PhACs [64]; however, this technology is found to be 
quite expensive and shows low quantum yield of light adsorption along with low efficiency 
[64]. Additionally, secondary operations are required for the purpose of recovering 
catalysts after use. Ozonation can remove 30-80% IBP, 65-100% NPR and ~96% DCF; 
nevertheless, the ozonation products formed are currently unknown. In general, higher 
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doze of ozone is required for complete removal of organic contaminants which is very 
expensive [16]. Besides, ozone is unstable and cannot be stored and therefore, it must be 
generated on site [65]. Although Membrane Bioreactor can remove almost >99% of PhACs 
from water [66], competences of diverse microbial population in the eradication of selected 
pharmaceuticals and optimization of design and operating settings are crucial for the 
success of this methodology [67].  
2.3 Nanofiltration 
Nanofiltration (NF) is a pressure-driven membrane process placed between ultra-
filtration (UF) and reverse osmosis (RO) with respect to size discrimination. Recently, NF 
and RO removal mechanisms are becoming more and more popular because of their utmost 
importance in eliminating micro-pollutants [21, 22, 68, 69]. In microfiltration (MF) and 
UF membranes, pore sizes are 100 to 10,000 times larger than the size of micro pollutants 
and therefore UF and MF are not effective in removing organic contaminants [16, 70]; 
whereas in RO and NF, a transmembrane pressure is applied to force the water transport 
through “pores”, thereby retaining the contaminants on the membrane by charge and size 
interactions [34]. Although RO will achieve almost complete removal due to a tighter 
membrane structure than in the case of NF, the lower operating pressure (10-50 bar), higher 
flux rate, high retention of multivalent anions, relatively low investment, low operation and 
maintenance costs and environmental friendliness make NF as a more enhanced option 
than RO [21, 34, 38, 71]. NF membranes have pore sizes between 0.2 and 0.4 nm [21, 72] 
and can eradicate most of the trace micro pollutants including natural hormones, a wide 
variety of pesticides, phthalate, polycyclic aromatic hydrocarbons (PAHs), 
trihalomethanes (THMs) and their precursors [14, 16, 22, 34, 73, 74]. Achievement of high 
quality effluents including extremely low concentrations of organic compounds and the 
removal of microbes and viruses without chemical disinfection is one of the remarkable 
advantages of membrane processes, when compared to the conventional treatment ones 
[22]. Therefore, they are being used progressively for treatment by both water and 
wastewater industries, thereby offering a valuable tool to concentrate and recover a variety 
of organics [21, 75].  
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2.3.1 Thin Film Composite (TFC) Membranes 
Thin film composite (TFC) membranes have been shown to be excellent candidates 
for a wide variety of separation applications, particularly in water and wastewater 
treatments [76] with high permeability under ultralow pressure [77]. TFC membranes can 
be used for separation of polyvalent ions and chemicals with molecular weight within a 
range of 100 and 1,000 [77]. Most of the available commercial NF membranes are TFC 
membranes formed through interfacial polymerization (IP), an established technique in 
which a polyamide (PA) active layer is synthesized on a polymeric support layer. The ultra-
thin layer of TFC membranes are fabricated through IP of two monomers [78, 79] that are 
usually dissolved in immiscible solvents like water and hydrocarbon solvents [71, 76, 80-
82]. The IP occurs in the interface between the two phases in two steps: first, the support 
is impregnated with an aqueous polyfunctional amine solution; and then it is put into 
interaction with an organic solvent containing a polyfunctional acid chloride [76, 79]. An 
ultra-thin (tens of  nm to several µm) dense layer (top selective layer) is formed on a support 
porous substrate [71, 80, 82] and each of the layers can be independently adjusted and 
controlled to attain the anticipated solute separation rate and water permeability of the NF 
membrane [76, 77]. The ability to develop extremely thin layers of barrier materials from 
almost any conceivable chemical combination makes TFC technology a great success. 
Along with that, this method offers an excellent mechanical strength and compression 
resistance of the resulted material [76].  
2.3.2 Synthesis of Thin Film Composite (TFC) Membranes 
The performance of a membrane is determined by pore dimensions, thickness, 
roughness, hydrophilicity/hydrophobicity, cross-linking and functional bonds [76]. Since 
the productivity flux and membrane thickness are inversely proportional to each other, the 
synthesis of the thin membranes is of ultimate significance.  
The development of dense membrane structure and hence the performance of the 
membrane are usually reliant on the porous support layer. The support of a TFC membrane, 
which is usually MF/UF membrane, is developed through the phase inversion method, in 
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which a film of concentrated polymer is cast on an appropriate substrate and successively 
submerged into a non-solvent bath [77, 79, 83-85]. Thus, the interchange of solvent and 
phase separation takes place in the casting film.  Usually, polysulfone (PSF) is proved to 
be the most appropriate polymer to form the substrate layer by many researchers [76, 81, 
85-87] because of its availability, ease in processing and stability against thermal, 
mechanical, chemical and bacterial occurrence [81]. PSF is a rigid, amorphous, transparent 
polymer with high molecular weight and is soluble in a number of organic solvents, such 
as ethylene chloride, dimethylformamide (DMF) and N-methylpyrrolidone (NMP) [88]. 
Despite the excellent properties and broad usage in water purification, biochemistry, gas 
separation and drug extraction, PSF membranes have the major disadvantage of high 
hydrophobicity. This is an issue that renders PSF membranes easily susceptible to fouling 
[83, 88]. As a result, the flux through the PSF membranes declines and the rejection of 
contaminants, such as heavy metals, natural organic matter, salts, bacteria and viruses, 
becomes low [83]. One approach to increase the membrane’s hydrophilicity is the use of 
PSF and polyethersulfone (PES) with some modifications that find a compromise between 
hydrophobicity and hydrophilicity and localize the hydrophilic materials in the membrane 
pores increasing flux and reducing fouling [88]. Graft polymerization, plasma treatment, 
physical pre-adsorption of hydrophilic components to the membrane surface, surfactant 
modification, self-assembly of hydrophilic nanoparticles and membrane nitrification are 
some of the modification processes [88]. On the other hand, sulfonation, carboxylation and 
nitration are techniques by which the membrane polymers get modified before the 
preparation of membranes [88]. Song et al. [77] added sulfonated polysulfone (SPSF) into 
the porous PSF substrate to improve the hydrophilic property and binding capacity of the 
NF membrane. Membrane with PSF/SPSF blended support modified the asymmetric 
membrane structure with a higher permeability than that with PSF structure and could be 
successfully used in separating polyvalent ions, softening underground water, and 
purifying wastewater under low pressure with a wide pH range [77]. Several researchers 
have found that the blend of carbon nanotubes (CNTs) and PSF resulted in a new composite 
membrane with improved properties [89, 90]. According to Choi et al. [84], CNT/PSF 
composite membranes are more hydrophilic with smaller pores than pure PSF membranes. 
In that work, multi-walled carbon nanotube (MWCNT)/PSF blend composite membrane 
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was fabricated through phase inversion method, using water as a coagulant [84]. MWCNTs 
were surface-modified with concentrated nitric acid (HNO3) and sulphuric acid (H2SO4) 
(1:3 vol%) because acid-treated MWCNTs are known to have carboxyl groups on their 
surfaces showing easy dispersion in organic solvent, NMP [84]. Exactly 0.5%, 1%, 1.5%, 
2% and 4% of MWCNTs were added with 20% PSF in NMP. Celik et al. [91] synthesized 
MWCNT/PES blend membranes through phase inversion method and produced more 
hydrophilic membranes with higher flux than the pristine PES membranes. Along with that 
this membrane showed less membrane fouling caused by natural water. The CNTs used 
were functionalized through reflux with 3:1 (v/v) HNO3:H2SO4 and the solvent used was 
NMP. With an increase in MWCNT in the blend material, the flux increased; 2% MWCNT 
in 20% PES decreased 64% more of foulant than on bare PES membranes [91]. The work 
of Yokwana et al. [83] focused on the fabrication of nitrogen and phosphorous doped 
carbon nanotubes (fN-CNTs and fP-CNTs) and PSF blend membranes. They also used 
phase inversion method to prepare a membrane made with 15% PSF dissolved in 
dimethylacetamide (DMAc) and CNTs, and functionalized by a refluxing procedure. The 
purpose of using fP-CNTs and fN-CNTs was to improve hydrophilicity, thermal stability, 
water uptake and surface charge. Research showed that doped CNTs lead to the formation 
of “finger-like” structures that resulted in better membrane porosities and pore sizes. Ionita 
et al. [92] utilized graphene oxide (GO) to make a PSF-GO composite membrane through 
phase inversion method. In that process, DMF was used to dissolve 20% PSF and later GO 
was added to the homogenous polymer solution. Ethanol was used as the non-solvent 
where the PSF-GO solution, cast on a glass plate, had been immersed to complete the phase 
inversion method. 
The principal concept of the IP is to select the correct partition coefficient of the 
monomers in the two-phase solution along with setting the appropriate diffusion speed 
which gives the ideal degree of densification of the ultra-thin layer [71]. The widely-used 
monomers are m-phynylenediamine (MPD) in aqueous phase and trimesoyl chloride 
(TMC) in organic phase. This combination has been commercially utilized to fabricate the 
TFC membrane [76, 78]. Xie et al. [93] indicated MPD concentration of 1.5-2% as 
optimum for ideal membrane performance and suggested that higher MPD concentration 
resulted in thicker barrier layer and lower membrane performance [93]. On the other hand, 
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lower MPD concentration causes less diffusion of the amine to the organic phase, creating 
a thinner, less rough and defective layer with lower permeability and lower selectivity [94]. 
Meihong et al. [71] studied the development of TFC-NF membranes through IP of 0.2% 
piperazine (PRP) in DI water and 0.26% TMC in hexane and their performance for the 
removal of sulfate ions from concentrated aqueous salt solution. The support used for this 
IP was commercially available microporous PSF. Song et al. [77] synthesized the active 
skin layer by reaction between polyamine (p-phenylenediamine (PPD), MPD or PRP) in 
deionized (DI) water and TMC in hexane. Under ultra-low pressure (0.3 MPa), the 
membranes showed higher selectivity with reasonable flux rates for polyvalent ions than 
for monovalent ions [77]; PPD/TMC & MPD/TMC showed higher selectivity and lower 
permeability than PRP/TMC. Jeong et al. [95] reported the formation of mixed matrix RO 
membranes through the IP of nanocomposite thin films on porous PSF supports. The thin 
film was fabricated using 2% MPD and 0.1% TMC in n-hexane; the aqueous 
nanocomposite membranes were made by dispersing 0.004-0.4% of synthesized zeolite 
nanoparticles in the hexane-TMC solution. The purpose of selecting super hydrophobic, 
negatively charged, molecular sieve zeolite particles was hypothesized to provide 
preferential flow paths for water permeation while maintaining high solute rejection 
through combination of steric and Donnan exclusion [95]. The loading of zeolite into the 
TFC membranes affected the permeability of membranes; with a rise in zeolite loading, a 
growth in permeability was observed. Qiu et al. [96] prepared RO composite membrane 
with extra thin separation layer through IP of 2% MPD and 0.3% TMC on PSF support. 
The permeability and salt rejection capacity of TFC membranes depended highly on the 
concentrations of the monomers [96], especially MPD. Qui et al. [96] tried some phase-
transfer catalyst so that monomers could diffuse to the phase interface and allow chemical 
reaction to proceed. The concept behind this was that the presence of phase transfer catalyst 
can transfer the complex compound of one monomer to the other phase in which the other 
monomer is dissolved and, as a consequence, both monomers could collide with each other 
in the same phase [96]. Cetyltrimethylammonium bromide was used as a phase transfer 
catalyst and it was found that when the concentration of MPD was low, it had notable 
consequence on both salt rejection and flux. The reason behind this improvement in IP 
yield was the introduction of hydrophobic functional groups that showed one kind of ionic 
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surfactant, the effect of electrostatic exclusion helped the salt rejection and the introduction 
of ionic surfactant changed the binding energy between support layer and top layer that 
eventually influenced the property of the membrane. Qui et al. [96] also experimented the 
addition of isopropyl alcohol (IPA) and phenol to the MPD aqueous solution before the IP. 
The reason behind was that since alcohols and phenols are hydrophilic reagents, their 
addition to the monomers in water phase causes the hydroxyl to react with acylchloride of 
TMC changing the physico-chemical properties of composite membranes, forming 
structure of ester and thus improving the flux. Addition of IPA and phenol increased 2.5 
times the initial flux with fairly constant rejection [96]. Hermans et al. [79] used a 
simplified method in which the phase inversion step and impregnation with the amine 
monomer were accomplished instantaneously by accumulating the amine to the 
coagulation bath before the cast polymer was immersed in it [79]. PSF-UF membranes 
were cast by phase immersion method (PSF in NMP) and then immersed in aqueous amine 
solution with 2% MPD, 2% trimethylamine (TEA) and 0.1% sodium dodecyl sulfate (SDS) 
whereas the organic solution was represented by 0.1% TMC (w/v) in n-hexane. The 
research showed that without compromising with membrane performance, the simplified 
method was able to reduce the required PSF concentration (16 and 18% PSF) compared to 
the traditional IP technique (20% PSF). The addition of TEA and SDS together had a 
positive impact on both water permeability and membrane selectivity. Ghosh et al. [81] 
dissolved 18% PSF in NMP to prepare the porous support; prepared the aqueous amine 
solution by dissolving 2% MPD, 2% TEA and 4% camphor sulfonic acid (CSA) in DI 
water and organic solution by dissolving 0.1% TMC in n-hexane [81]. Seman et al. [97] 
used Bisphenol A (BPA) as aqueous solution and TMC in n-hexane as organic solution to 
create thin film on asymmetric commercial membrane NFPES10.  With an increase in BPA 
concentration, the thickness of the membranes increased exhibiting lower permeability. 
Barona et al. [78] synthesized TFC membrane by incorporating single-walled nanotubes 
(SWNT) in a polyamide matrix to increase the hydrophilicity and thus pure water flux.  
Commercial PSF-UF membranes were used as support, 2% (w/v) MPD served as aqueous 
monomer and 0.1% TMC (w/v) with 0.05%, 0.1% and 0.2% (w/v) SWNT in n-hexane 
acted as organic monomer in their research work [78]. The addition of 0.59 wt% SWNT in 
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the membranes increased the pure water flux a 1.5-fold magnitude compared to that of a 
TFC membrane without SWNT [78]. 
Drazevic et al. [98], on the other hand, examined the effect of coating layer on the 
performance of TFC membrane. They layered commercial NF membrane NF270 with 
polyvinyl alcohol (PVA) layer and found that the coating resulted in an increase of 5 to 
30% in the rejection of hydrophobic solutes and a decrease of 6 to 50% in the rejection of 
hydrophilic solutes [98]. PVA has been proved to have enormous prospective as an NF 
membrane material due to its numerous amounts of hydroxyl groups on the membrane 
surface revealing a polar character [86]. Peng et al. [99] synthesized a composite NF 
membrane by coating commercial PSF-UF membrane with 0.1wt% PVA, cross-linked 
with maleic acid (MA) to get 20% cross-linking degree. Gohil and Ray. [86] prepared a 
TFC membrane with 17% porous PSF as base support and 1% PVA, cross-linked with 
0.2% (w/w) MA as the barrier layer [86]. Maphuta et al. [87] prepared CNT impregnated 
polymer composite membranes with PVA barrier layer to separate oil from water.  
2.3.3 Separation Performance of Thin Film Composite (TFC) 
Membranes 
 Jeong et al. [95] carried out the permeability and separation performance of TFC 
membranes, synthesized with MPD, TMC and zeolite nanoparticles, in a high pressure 
chemical resistant stirred-cell (HP-4750). When the amount of zeolite nanoparticles was 
increased in the TFC membranes, the permeability increased from 2.1± 0.1x10-12 mPa-1s-1 
to 3.8± 0.3x10-12 mPa-1s-1 [95]. Yokwana et al. [83] utilized a cross-flow membrane testing 
unit with an effective membrane area of 18.30 cm2 for permeability and selectivity tests of 
functionalized doped CNT/PSF NF membranes. Although 0.3% fN-CNT/PSF showed the 
maximum flux of 84.7 L.m-2.h-2, 0.5% fN-CNT/PSF showed the highest rejection of 
magnesium sulfate (MgSO4) (95%) [83]. The TFC membrane prepared with 0.2% aqueous 
PRP and 0.26% TMC in hexane exhibited a water permeability coefficient of 75 L.m-2.h-1 
MPa with 67% rejection of sodium chloride (NaCl) and 98% rejection of MgSO4 at 1 MPa 
[71]. Song et al. [77] found that when the support of the TFC membranes prepared with 
MPD/PPD/PRP and TMC was PSF/PSF alloy substrate, there was an amplification in the 
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permeability of the membranes. For MPD/TMC membranes, this increase was 4.0 to 6.1 
L.m-2.h-1; for PPD/TMC, the rise in flux was from 2.8 to 4.0 L.m-2.h-1; whereas an increase 
from 8.0 to 13.2 L.m-2.h-1 was visible for PRP/TMC membranes [77]. In case of 
MWCNT/PSF blend membranes, at a pressure of 4 bar, maximum pure water flux of ~21 
m3/m2-day was observed when 1.5 wt% MWCNT was used [84]. Qiu et al. [96] found that 
the concentrations of MPD and TMC in TFC membranes significantly impact the pure 
water flux and rejection capacity of the membranes. When the TMC concentration raised 
from 0.05 to 0.4% (w/v), there was a 20% decrease in water flux; whereas with an increase 
of MPD concentration from 0.8 to 2.4% (w/v), the flux dropped ~34% [96]. Hermans et al. 
[79] synthesized TFC membrane via a simplified method and indicated that with 2.5% 
MPD in coagulation bath and 18% PSF, at 15 bar, membrane permeance was 4 L.m-2.h-
1.bar-1 and MgSO4 rejection was 99%. The TFC membrane prepared by Gohil and Ray [86]  
achieved 22.8% and 83.8% rejection of NaCl and MgSO4 respectively. Table 2.4 gathers 
the permeability and rejection capacity of chosen TFC membranes. 
Table 2.4: Permeability and Separation Performance of TFC Membranes 
Membranes Flux  
(L.m-2.h-1) 
Rejection of 
NaCl (%) 
Rejection of 
MgSO4 (%) 
 
Reference 
MPD/TMC 19 96 - [96] 
MPD/TMC 5-7 - 95-97 [100] 
MPD/TMC 42 99.8 - [101] 
MPD/TMC 60 95 - [102] 
MPD/TMC 25.8 96.4 - [103] 
MPD/TMC 82 95.3 - [104] 
PRP/TMC 5-20 - 85-95 [77] 
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PPD/TMC 2-5 - 92-99 [77] 
PIP/TMC 75 67 98 [71] 
0.3% fN-CNT/PSF 84.7 31.6 92.6 [83] 
0.3% fP-CNT/PSF 72.6 32.3 93.3 [83] 
0.5% fN-CNT/PSF 51.3 33.5 95 [83] 
MPD/TEA/SDS 33.75 - 99 [79] 
PSF/PVA/MA  12.5 - 90 [86] 
NTR-7250 
(commercial)  
62.5 50 98 [71] 
Desal-5 
(commercial)  
47.1 50 96 [71] 
NF-70 (commercial)  72 70 98 [71] 
 
2.4 Organic Solvent Nanofiltration (OSNF) Membranes 
Another type of NF is the organic solvent nanofiltration (OSNF) which is an energy 
efficient separation process showing high potential in different branches of industry [105]. 
The OSNF is proficient at separating molecules of 200-1,000 g/mol in several organic 
solvents [105]. According to literature, most of the OSNF membranes are asymmetric and 
integrally skinned, and made of polyamides (PI) or composites consisting of a thin 
poly(dimethyl siloxane) (PDMS) separating layer on various types of supports, such as: 
PES [106, 107]; PSF [108, 109], polyamide [110], polyimide (PI) [111], polyacrylonitrile 
(PAN) [112], cellulose acetate [113, 114], polytetrafluoroethylene [115], ceramic porous 
support [116-118], polyethylene-perforated metal support [119] etc. Chemical, thermal and 
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mechanical stability are the general requirements for the supporting layers [120]. Along 
with that, strong adherence of the support layer to the top layer as well as high porosity are 
also important criteria [120]. 
2.4.1 Poly (dimethyl siloxane) PDMS 
Poly (dimethyl siloxane) (PDMS) is known to be the most commonly used 
hydrophobic material with elastic behaviour, resistance to high temperatures, light 
degradation and chemical attack that has been efficaciously applied for the preparation of 
membranes used in different purposes [121, 122]. PDMS is a biocompatible, cheap and 
easy to use [123] elastomer with an inorganic siloxane (Si-O) backbone and organic methyl 
groups attached to the silicon atoms [122, 124]. Its non-polar, hydrophobic nature makes 
PDMS susceptible to swelling in the presence of alkane and aromatic solvents [125]. 
PDMS is highly soluble in non-polar solvents; thus to make it chemically stable, the cross-
linking of PDMS is necessary and various applications, such as- electrical/optical devices 
[126], anticorrosion [127], anti-fouling material [128] as well as biomedical applications 
[129, 130] have found cross-linked PDMS to be very suitable.  To attain the chemical 
stability, it is necessary to create a three-dimensional cross-linked network by reacting the 
functional vinyl end groups on the linear PDMS chains with a multifunctional cross-linker 
in the presence of a catalyst [121, 124, 125, 131]. Since the addition of hydrosilation has 
been normally utilized for the synthesis of cross-linked PDMS materials [132, 133], the 
rate of hydrosilation, the vinyl group of the PDMS, the number of Si-H groups on the cross-
linker, the concentration of the cross-linker as well as the type and molecular structure of 
the catalytic complex are of important concern. For vinyl terminated PDMS, according to 
Esteves et al. [121], the most credible reaction is the β-addition of a silicon hydrogen to the 
vinyl bond (Eqn 2.1). 
  R-Si-H + CH2=HC-Si-R                  R-Si-CH2-CH2-Si-R…………… (2.1) 
According to Stein et al. [134], the hydrosilation reaction,  in the presence of a 
platinum catalyst, continues in three phases: the induction period, a rapid exothermic 
regime and finally a post-curing stage. In the induction period, the active species of the 
catalysts are formed; during the rapid exothermic regime, most of the products of the 
Heat and catalyst 
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hydrosilation reaction are formed whereas in the post-curing stage, the hydrosilation 
reaction ensues very slowly or ends [121]. The performance of PDMS membranes depends 
on the terminal group, PDMS to cross-linker ratio, cross-linking density, PDMS chain 
length etc. [108]. The degree of cross-linking of the silicone network is a very important 
factor in the characteristics of the NF membranes [135]. During the synthesis of PDMS 
membranes, the optimization of inter-chain bonding of PDMS oligomers depends on two 
main factors: a) the chemical curing agents and catalysts b) the cross-linking temperature. 
Simpson et al. [100] noted that the rate of polymerization is linearly proportional to the 
catalyst concentration. Berean et al. [123] studied the effect of cross-linking temperature 
on the permeability of PDMS membranes and found that an optimal temperature of 75oC 
resulted in membranes with the highest gas permeation. Dutczak et al. [105] showed that 
adjusting the viscosity of the PDMS coating solution highly affects the quality of the 
PDMS layer in a composite membrane and a better control of viscosity can be 
accomplished at a temperature around 50oC.  
2.4.2 Preparation of Organic Solvent Nanofiltration Membranes 
with PDMS 
Literature reports several methodologies to synthesize composite PDMS 
membranes, for example, filling the pores of a support layer with an active PDMS layer 
[117], dip-coating [136] and pressing [137]. During the dip-coating process, the spreading 
velocity of the PDMS solution as well as the dip-coating time plays an important role in 
PDMS film thickness. The thickness increases with an increase in PDMS concentration as 
well as with a dipping time. Stafie et al. [112] prepared a composite membrane with PAN 
as a support and PDMS as the selective top layer for the recovery of hexane from oil/hexane 
and PIB/hexane mixtures [112]. As PDMS, RTV615 consisting of a vinyl-terminated pre-
polymer with high molecular weight (RTV A) and a cross-linker having several hybrid 
groups on shorter PDMS chains (RTV B) with a ratio of 10:1 had been used [112]. Pt-
catalyzed hydrosilylation reaction caused the curing of PDMS membrane that resulted in a 
densely cross-linked polymer network. The PAN support was dip-coated in 5 and 7 wt% 
pre-cross-linked PDMS-n-hexane solution. The pre-cross-linking was done at 60oC for 3 
hours. Then the membrane was dried in air for 10 minutes and the final cross-linking was 
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performed for 4 hours at 65oC. Membranes made with 5% (w/w) PDMS showed coating 
layer with defects due to the low viscosity,  whereas 7% (w/w) PDMS coating provided a 
much better quality top-layer [112]. In another study, Stafie et al. [135] studied the 
influence of cross-linker amount of 6.5, 9.1 and 16.7% corresponding to the pre-polymer 
cross-linker ratio of 10:0.7, 10:1 and 10:2 respectively on the membrane swelling and 
permeation properties [135]. The research found that hexane permeability through the 
PAN/PDMS composite membrane synthesized at a pre-polymer/cross-linker ratio of 10:0.7 
was higher than that of the ratio of 10:2 and 10:1; the apparent viscosity inside the 
membrane and higher membrane swelling were the reasons for the difference in 
permeability [135]. Dutczak et al. [105] investigated the preparation of composite capillary 
membranes consisting of commercial Hyflux InoCep M20 α-alumina support with tailor-
made PDMS (RTV 615) top layer. A 15% PDMS solution was diluted up to 3.75% as 
lower PDMS concentration is vital to preparing a thin selective layer of the membrane 
[105]. Moreover, the low concentration PDMS solution was pre-crosslinked to get a higher 
viscosity as low viscosity PDMS solution produced defected top-coat. Dutczak et al. [105] 
also found that, to prepare a good PDMS composite membrane, the pore size of the support 
should be small, otherwise the coating solution intrudes significantly into the pores of the 
supports and blocks the pores which eventually decreases the permeability of the 
membrane [105, 120]. 
Dobrak-Van Berlo et al. [122] studied the importance of solvent parameters (such 
as  viscosity, molar volume) and solvent-membrane interaction parameters (such as 
swelling) and  difference in surface tension in both NF and pervaporation (PV) by 
preparing both unfilled and filled membranes from 10% PDMS solution. The PI support 
layer was prepared from a PI solution containing 15 wt% PI, 2 wt% H2O, 62.25 wt% NMP 
and 20.75 wt% tetrahydrofuran (THF). This solution was cast on a polypropylene non-
woven support with a casting knife; after casting, the solvent was allowed to evaporate for 
30 secs and then the membrane was immersed in water at room temperature. Subsequently, 
the membrane was immersed in para-xylenediamine/methanol (1:10, w/v) mixture for 24 
hours for the purpose of cross-linking the PI and then rinsed with methanol. These 
membranes were furthermore treated through solvent-exchange procedure. To coat this PI 
support, a 10% pre-cross-linked PDMS solution (RTV 615A and B, pre-polymer and cross-
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linker in a 10:1 ratio) in hexane was used. For zeolite filled PDMS membrane, 15 wt% of 
silicate zeolites was used in the PDMS solution. This assimilation of zeolite lessened 
swelling and enhanced retention capacity of the membrane [122].  In this study, for dense 
PDMS and PI membranes the transport mechanisms were investigated using a wide range 
of solvents and pressures [122]. 
Madaeni and Hoseini [138] fabricated a series of membranes with PES as support 
and PDMS as active layer for the separation of ethylene from nitrogen. The PDMS used 
was Sylgard 184 silicone elastomer, consisting of polymer base and hardener. The polymer 
base consisted of dimethylsiloxane, dimethyl vinyl terminated, dimethyl vinylated and 
trimethylated silica as well as tetra (trimethylsiloxy) silane while the hardener consisted of 
dimethyl methylhydrogen siloxane tetramethyl tetravinyl cyclotetrasiloxane. The 
asymmetric PES support was synthesized by a phase-inversion method using NMP and 
dimethylsulfoxide as solvents. PDMS (base: hardener = 10:1), dissolved in n-hexane, was 
used to top-coat the PES support and left at room temperature for several days for drying. 
Madaeni and Hoseini [138] found that lower concentration of the support polymer created 
wider pores and less tight membranes; on the other hand, dense PDMS coating layer 
resulted in lower nitrogen permeability. The best performance for ethylene permeance was 
achieved for membranes prepared from 20 and 22% PES, 9% coating solution and 35-50 
µm thickness [138].  
Wei et al. [139] prepared cross-linked PDMS/ceramic composite membranes by the 
conventional dip-coating method. Here tubular asymmetric ZrO2/Al2O3 membranes were 
used as ceramic supports and blend cellulose acetate MF membrane was used as a polymer 
reference membrane [139]. Exactly 10wt% α,ω-dihydroxypolydimethylsiloxane was 
dissolved in n-heptane with tetraethoxysilane (TEOS)/PDMS weight ratio 0.1 and 0.2wt% 
dibutyltin dilaurate catalyst was used as the coating solution. The supports were pre-wetted 
with water before dipping into polymer for the fact that since the pores of the supports were 
filled with water, the penetration of coating solution into the pores was significantly 
reduced and that improved the permeability. This study supported the work of Vankelecom 
et al. [120]. They also found that composite membranes prepared with higher molecular 
weight PDMS exhibited higher separation and lower permeate flux. 
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Li et al. [113] prepared PDMS composite membranes by top-coating pre-wetted 
cellulose acetate MF membranes with α,ω-Dihydroxypolydimethylsiloxane, cross-linking 
agent Tetraethylorthosilicate (TAOS) and catalyst dibutyltindilaurate in a ratio of 10:1:0.2 
in n-heptane. The membrane was initially cross-linked at room temperature for 2 hours and 
then finally at 60oC for 4 hours. These membranes showed remarkable high permeate flux 
for ethanol [113]. 
Jadav et al. [140] used a mixture of hydroxyl terminated polydimethylsiloxane 
(HPDMS) and polymethylhydrosiloxane (PHMS) in n-hexane (HPDMS:PHMS=10:1) 
with dibutyltindilaurate as the catalyst to prepare the polymer solution [140]. For free-
standing PDMS membrane, the PDMS concentration used was 20% whereas for composite 
membrane, a diluted PDMS concentration (0.05-5%) was used to top coat PSF support 
[140]. Cross-linking was finalized by putting the membranes in an oven at 80oC for 1 hour.  
The neat PDMS membranes showed non-porous, dense, relatively smooth surfaces; on the 
other hand, when the coating was done with dilute PDMS solution, more polymer could 
penetrate the porous support, making the membrane structure loose upon decreasing its 
thickness and exhibiting larger crystalline domains on the surface of the composite PDMS 
membranes [140]. These polymer clusters or crystals could be produced with defects 
showing high permeability of water and methanol but low selectivity [140]. Kim et al. 
[141] used three types of supports, such as-non-woven fabric, PSF-UF membrane, non-
woven fabric treated with polyethylene glycol (PEG, MW=10,000) aqueous solution to 
prepare PDMS composite membranes and compared the removal capacity of toluene. The 
study found that the membranes with PEG-treated non-woven fabric support layer showed 
the best performance in toluene removal.  Since water soluble PEG had been used as a 
clogging medium, the PDMS intrusion in the pores was prevented increasing the toluene 
flux over the other two types of membranes [141].  
The incorporation of filler-like nanoparticles into polymer matrix and then coating 
with PDMS is a recent trend in membrane technology that has been used to improve the 
gas separation performance. Jomekian et al. [142] incorporated MCM-41, both unmodified 
and modified with dimethyldichlorosilane (DMDCS) nanoparticles in 20% PSF to prepare 
a MCM-41/PSF nanocomposite membrane; N,N-dimethylacetamide (N,N-DMAc) had 
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been used as a solvent. The mixture of MCM-41/PSF was cast on a glass plate with a 
casting blade and the support was prepared using the phase-inversion method [142]. 
Exactly 5, 7 and 30 wt% PDMS was dissolved in n-hexane and the MCM-41/PSF support 
was dip-coated with a given PDMS solution. Final cross-linking was done in an oven at 
100oC for 24 hours. Scanning Electron Microscopy (SEM) images showed that the mixture 
of unmodified MCM-41 and PSF created unfavorable voids between polymer matrix and 
inorganic material whereas MCM-41 modified with DMDCS ensured higher dispersion in 
PSF resulting in no distinct voids between two phases [142]. PDMS coating on the 
membrane surface controlled the permeation and ideal selectivity of membrane through the 
concentration of coating solution [142].  
To prevent the pore intrusion, several techniques have been applied by researchers: 
some found that filling the support pores with a non-solvent [143, 144] for the coating 
polymer or with a solvent [145] before applying the coating solution could reduce the pore 
intrusion. Another way is to fill the pores with high viscosity materials [146]. Some authors 
suggested the casting of top layers from a concentrated solution to form a gel as soon as 
the support is contacted for limiting the penetration [147].  Vankelecom et al. [120] tried 
pretreatment of support layers by combining different solvent exchange steps (IPA, n-
hexane and water) before applying a selective layer on the support. PSF, PAN and Zirfon 
(PSF membranes containing Zirconium dioxide, ZrO2 fillers) membranes were used as 
supports whereas RTV 615A and RTV 615B were used as prepolymer and cross-linker 
(RTV A: RTV B=10:1) respectively in the study. PDMS concentrations ranged between 
10 and 20% (v/v) that was pre-cross-linked for 30 minutes at 70oC. Final cross-linking was 
done at 150oC for 1 hour. Pervaporation with 6 wt% aqueous ethanol or t-butanol solutions 
was done to evaluate the performance of these membranes [120] and it was found that 
water in the pores of the supports was perfect to coat with PDMS dissolved in hexane [120] 
to reduce intrusion. Jomekian et al. [142] showed that higher PDMS concentration (30 
wt%) prevented the undesirable penetration of PDMS during dip-coating into pores of 
supports and thus showed remarkable increase in selectivity of gases.  
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2.4.3 Performance of Organic Solvent Nanofiltration Membrane 
Stafie et al. [112] tested performance of PDMS membranes through a dead-end 
filtration system. According to their study, the solution-diffusion model described the 
hexane transport through the membrane and both the flux and solute retention depended 
on the applied transmembrane pressure and feed concentration. The permeability of hexane 
decreased with an increase in oil concentration in the oil/hexane feed [112]. Table 2.5 
summarizes the performance of PAN/PDMS composite membranes for various oil/hexane 
feed concentrations.  
Table 2.5: Performance of PAN/PDMS Composite Membranes for Various 
Oil/Hexane Feed Concentrations [109] 
Transmembrane 
Pressure (bar) 
Hexane Flux (L.m-2.h-1) 
Pure hexane 8% w/w 
(oil/hexane) 
19 % w/w 
(oil/hexane) 
30 % w/w 
(oil/hexane) 
1 4 - - - 
2 8 2.5 - - 
3 12 5 - - 
4 16 7.25 2.5 - 
5 20 8.5 5 1 
6 24 11 6 2 
7 27.5 12.5 7.5 4 
 
39 
 
In another study [74], it was found that, PAN/PDMS composite membrane with the 
pre-polymer/cross-linker ratio of 10/0.7 showed the highest hexane permeability of 4.5 
L.m-2h-1bar-1. Table 2.6 shows the hexane permeability of some of the OSNF membranes. 
Stafie et al. [135] also studied the hexane permeability of PAN/PDMS for various 
PIB-1300/hexane feed concentrations (Table 2.7).  
Dutczak et al. [105] performed the permeation experiments in a custom-made 
cross-flow high pressure permeation set up equipped with an HPLC pump that could 
pressurize the set-up up to 40 bar. It was found that the composite capillary membrane 
developed in this study M20/55 (where M20 represents Hyflux InoCep M20 support and 
55 represents the viscosity in mPa-s of 3.75% PDMS solution) showed the highest toluene 
permeance of 1.6±0.11 L.m-2.h-1.bar-1 [105]. Vankelecom et al. [148] prepared a 
polyacrylonitrile-polyester/PDMS (PAN-PE/PDMS) composite membrane with toluene 
permeance of 1.2 L.m-2.h-1.bar-1 whereas a commercial silicon-based membrane, MPF-50 
(Koch) had a toluene permeance of 1.3 L.m-2.h-1.bar-1 [149]. The use of PDMS membranes 
for separation of ethanol from an aqueous solution is of great importance. Table 2.8 
provides an overview of pervaporation data for the separation of ethanol from dilute 
aqueous solution with PDMS membranes. 
Table 2.6: Hexane Permeability of Chosen OSNF Membranes [60, 78-80] 
Membrane 
Permeability of Hexane 
(L.m-2.h-1.bar-1) 
Reference 
PAN/PDMS 4.5 [135] 
Pebax Composite Membranes 3-4.9 [150] 
D membrane from Osmonics 1.6 [151] 
MPF-50 1.52 [152] 
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Table 2.7: Performance of PAN/PDMS Composite Membranes (Pre-polymer/Cross-
linker ratio 10:0.7) for Various PIB-1300/Hexane Feed Concentrations [135] 
Transmembrane 
Pressure (bar) 
Hexane Flux (L.m-2.h-1) 
Pure hexane 
8% w/w (PIB-
1300/hexane) 
19 % w/w (PIB-
1300/hexane) 
1 - - - 
2 9.5 4 - 
3 14 n/a 1.25 
4 19 10 n/a 
5 n/a 13 5 
6 n/a n/a 6 
7 31 20 8.5 
 
Table 2.8:  Separation of Ethanol from Water with PDMS Membranes 
Membranes Mass % of 
Ethanol in 
Feed 
Permeation Flux 
(L.m-2.h-1) 
 
Separation 
Factor 
Reference 
PDMS/CA 5 4927 8.3 [113] 
PDMS/ceramic 5 6064 8.9 [139] 
PDMS/PVDF 10 3411 31 [153] 
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PDMS-
PS/PESF 
10 493 6.2 [154] 
PDMS/PS 8 1005 6.4 [155] 
 
2.5 Concluding Remarks 
Trace contaminants like PhACs and EDCs along with their degradation by-products 
have been increasingly detected in the aquatic environment. Because of the rapid 
development of sensitive analytical techniques, it has become possible to identify the trace 
amounts of these emerging contaminants in the environment. Nevertheless, despite their 
unidentified influence on human health and environment, there is, at present, no 
legitimately controlled maximum tolerable concentration of these chemicals in the 
environment. 
Since conventional wastewater treatment plants are not efficacious in thorough 
elimination of the trace contaminants from urban wastewater, more effective and precise 
treatment procedures are essential. AOPs, in the recent years, have shown quite effective 
removal efficiency for PhACs and EDCs; nevertheless, the investigation of their fate and 
transformation along with the by-products during these removal techniques are still largely 
unknown.  
A number of studies have identified nanofiltration technique as an established 
remedial procedure for emerging contaminants from water and thin film composite 
nanomembranes are dominating representatives for this category. Interfacial 
Polymerization has been known as a proven concept for the preparation of thin film 
composite nanofiltration membranes where an ultrathin selective layer is formed through 
interfacial cross-linking between reactive monomers over a porous support layer. 
Commonly, polysulfone (PSF), which is a rigid, transparent and high molecular weight 
polymer, has been extensively utilized to form the support layer of a TFC membrane. 
Whereas, aqueous m-phynylenediamine (MPD) and trimesoyl chloride (TMC) in n-hexane 
42 
 
are the most widely used monomers. The combination of PSF-MPD-TMC membranes 
were able to achieve a NaCl rejection of 95~99.8% and MgCl2 removal of 95~97% with a 
flux of 5~82 L.m-2.h-1. The infusion of functionalized multi-walled carbon nanotubes with 
the PSF polymer matrix often produced an improved flux. 
Organic solvent nanofiltration membrane is another emerging pressure-driven 
separation methodology having a number of advantages like flexibility and ease of 
production. Mostly, the OSNF membranes are asymmetric and integrally skinned; free-
standing or composites comprising of a thin poly (dimethyl siloxane) (PDMS) separating 
layer on different types of supports, such as polysulfone, ceramic acetate, polyacrylonitrile, 
polyethersulfone etc. The terminal group, PDMS to cross-linker ratio, cross-linking density 
and temperature, PDMS chain length, viscosity of PDMS solution etc.  are some of the 
factors affecting the characteristics of the OSNF membranes. Composite PDMS 
membranes synthesized in different studies have been used for gas permeation, separation 
of phase-transfer agent, solvent-deoiling, homogeneous catalyst recovery etc.  
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Chapter 3 
3 Materials and Methods 
This chapter discusses the materials and methods used in this study: the chemicals 
and instruments utilized for the detection of ibuprofen (IBP), naproxen (NPR), diclofenac 
(DCF) and 17α-ethinylestradiol (EE2), developed methodologies for the purpose of 
preparation, and characterization and evaluation of membrane performance. 
3.1 Chemicals and Reagents 
HPLC-grade (≥99%) hexane and methanol were purchased from Sigma Aldrich, 
Canada. Reagent grade dichloromethane and toluene were purchased from Caledon 
Laboratories Ltd.  For analytical determination, reference compounds for ibuprofen, 
diclofenac sodium salt, naproxen and 17α-ethinylestradiol (≥98%) were purchased from 
Sigma Aldrich, Canada. Anhydrous N,N-Dimethylformamide (99.8%), Polysulfone pellets 
(average M.W.~35,000), Trimethylsilyl-2,2,2-trifluoro-N-(trimethylsilyl) acetamide 
(BSTFA) (99.6%) and Multi-walled Carbon Nanotubes (6-9 nm x 5 µm, > 95% carbon) 
were also purchased from Sigma-Aldrich, Canada. For solid-phase extraction, Hypersep 
C18 cartridges were purchased from Thermo Scientific, Canada. PTFE laminated 
membranes (0.1 micron, non-woven polyester backer, 47 mm diameter) were purchased 
from Sterlitech Corporation, USA. ACS grade sulfuric acid and nitric acid were obtained 
from VWR Analytical, Canada. 
General Electric PDMS RTV 615 kit was purchased from Momentive Performance 
Materials. The silicon kit comprises two components: a) a vinyl terminated pre-polymer 
(RTV 615A) and b) a Pt-catalyzed cross-linker (RTV 615B) containing a polyhydrosilane 
component.  
SYLGARD 184 silicone elastomer kit, purchased from Sigma Aldrich, Canada, 
comprises of two parts: a polymer base and a hardener. The polymer base has a specific 
gravity of 1.05 g/cm3 at 25oC and a viscosity of 500 mPa-s; it is a viscous, colorless liquid 
comprised of dimethylsiloxane, dimethylvinilterminated, dimethyl vinilated and 
trimethylated silica as well as tetra (trimethylsiloxy) silane [1]. The hardener with a specific 
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gravity of 1.03 g/cm3 at 25oC and a viscosity of 110 mPa-s, consisted of dimethyl 
methylhydrogen siloxane tetramethyl tetravinyl cyclotetrasiloxane.  
Laboratory grade water was obtained with a Barnstead Easy Pure UV 45 Ultrapure 
water purification system (Barnstead, IOWA, U.S.A.). 
3.2 Collection of Wastewater Samples 
All glassware, supplies and containers were solvent rinsed three times each with 
acetone, hexane and methanol. To analyze pharmaceutically active compounds (PhACs), 
wastewater effluent samples were collected over a six-month period, from August 2015 to 
January 2016, from two WWTTPs: Greenway Pollution Control Plant and Adelaide 
Wastewater Treatment Plant, in London, ON, Canada. Whereas, to analyze EE2, effluent 
samples were collected from Adelaide Wastewater Treatment Plant in London, ON, 
Canada.  Triplicate grab samples were collected in both cases in clean and dry amber 
bottles. The samples were immediately filtered through 0.45 µm filters purchased from 
Whatman. For the analysis of PhACs, the samples were acidified to pH=1.95 with 
hydrochloric acid (HCl); on the other hand, EE2 analysis did not require any acidification. 
Subsequently the samples were stored at 4oC until further processing. Samples were 
processed within 24 hours of collection. 
3.3 Sample Preparation 
Analytical stock solutions of IBP, NPR, DCF and EE2 of 1 mg/mL were prepared 
in methanol and stored at -18oC. To prepare calibration curves, standards of different 
concentrations were prepared by diluting the stock solution in methanol. Synthetic samples 
with specific concentrations of pharmaceuticals and EE2 were prepared by spiking the 
desired amount of stock solution in Milli-Q water.  
3.4 Extraction and Derivatization of Sample  
Because of the very low concentration of EE2 and PhACs in water samples, pre-
concentration by solid phase extraction (SPE) or liquid-liquid extraction (LLE) is required 
before LC-MS or GC-MS analysis [2-4]. C-18, Oasis HLB and NH2 are the common types 
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of cartridges used in SPE [2, 4, 5] whereas dichloromethane (DCM) has been used as the 
solvent for LLE. 
3.4.1 Solid-phase Extraction 
In this study Hypersep C18 (6 mL, 500 mg bed) cartridge has been used to perform 
the SPE of EE2 (Figure 3.1). Total SPE procedure was carried out in 5 steps: i) 
conditioning, ii) loading, iii) drying, iv) elution and v) reconstitution. For the purpose of 
conditioning, 12 mL of methanol was initially passed through the cartridge at -3 in Hg (~11 
kPa), followed by 12 mL of deionized (DI) water at -5 to -8 in Hg (~20 kPa). The sample 
was then percolated through the cartridge at 1~2 drops/ sec at 20 kPa. The cartridge was 
subsequently allowed to dry for 5-60 minutes, depending on the type of elution solvents.  
Furthermore, a flow of hexane was allowed to go through the cartridge. Afterwards, elution 
took place by passing 15 mL of elution solvents at a rate of 1-2 drops/ sec at 20 kPa. Finally, 
reconstitution was performed by completely drying the collected volume with gentle flow 
of N2 and adding 100 µL of methanol for LC/MS analysis. 
 
Figure 3.1: Solid-Phase Extraction of Water Sample using Hypersep C-18 Column 
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3.4.2 Liquid-liquid Extraction 
According to U. S. Environmental Protection Agency (EPA) Method 625, liquid-
liquid extraction (LLE) with DCM followed by gas chromatography/mass spectrometry 
(GC/MS) analysis can be used for the determination of extractable organic pollutants in 
water. In the present study, to extract IBP, NPR and DCF, the LLE technique was used; 
whereas to do a comparison of extraction for EE2, both LLE and SPE were performed. To 
do a successful LLE, 50 mL of the samples were extracted with 50 mL of dichloromethane 
(Sample: DCM = 1:1), three times, by using a separatory funnel. The collected DCM 
extract was then evaporated using a BÜCHI Rotavapor®; here the water bath was 
maintained at 45°C (±2°C), until the remaining extract was about 1 mL. The extract was 
then moved to a 2-mL vial and completely dried with N2. In case of EE2, a reconstitution 
was done by adding 100 µL of methanol. This 100 µL extract was then analyzed on LC/MS. 
In the case of IBP, NPR and DCF, to be compatible with GC analysis, a sample 
derivatization was required to make the compounds more volatile [4, 6-9]. 
 
Figure 3.2: BÜCHI Rotavapor used to evaporate the sample obtained after LLE 
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3.4.3 Derivatization 
The core tenacity of analytical derivatization is to increase the volatility of the 
analytes by reducing the polarity of carboxylic (COOH-) or phenolic (OH-) functional 
groups, thereby increasing the thermal stability. In literature, acidic pharmaceuticals 
containing carboxylic moieties were found to be derivatized by silylation with N,O-
bis(trimethylsilyl) trifluoroacetamide (BSTFA), acylation with trifluoroacetic anhydride 
(TFAA), and benzylation with pentafluorobenzyl bromide (PFBB), or methylation with 
trimethylsulphonium hydroxide (TMSH) or diazomethane (CH2N2) [10-13]. In this study, 
samples were derivatized using pyridine (50 µL) and BSTFA (50 µL) at 70oC for 40 
minutes.  
The different sample preparation schemes for the analysis of EE2 and PhACs in 
wastewater and synthetic water are shown in Figure 3.5. 
3.5 Analytical Methods  
The reported low concentrations and small molecular weight (296.4 g/mol) of EE2 
present challenges in its analysis in complex matrices such as sludge and wastewater [14, 
15]. Along with that, lack of restrictive strategies to regulate the release of new compounds, 
by-products and pharmaceuticals into water and wastewater makes the analysis of EE2 
even harder [14]. Improved and advanced analytical and bioanalytical techniques 
comprised of highly sensitive instrumentation are therefore needed [9, 16].  
 
The most extensively used analytical technique for detection of EE2 has been found 
to be gas chromatography coupled with mass spectrometry (GC-MS) [6, 9, 16, 17]. Lately, 
the use of liquid chromatography coupled with mass spectrometry (LC-MS) has become 
more convenient than GC-MS due to its higher sensitivity, selectivity, simplicity, and the 
absence of derivatization steps [3, 4, 8, 9].  
 
The analytical measurements for EE2 were performed using an Agilent 6230 
TOF-LC/MS (Figure 3.3).  Liquid chromatographic separation was carried out at room 
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temperature using a Zorbax Eclipse Plus C18 (2.1 x 50 mm; 1.8 µ) Rapid Resolution High 
Through Column. For the separation of EE2, a programmed gradient was applied using 
water with 0.1% formic acid (A) and 0.1% formic acid in 90% acetonitrile (B) as solvents. 
The initial composition of the mobile phase was 70% A and 30% B. This level was held 
for 3 minutes and then was changed within 10 minutes to 40% A and 60% B. Next, within 
1 minute, B became 100% and this condition maintained for 3 minutes. In the next 1 
minute, A and B went back to the initial condition (70% and 30% respectively) and this 
continued for the next 7 minutes. The flow rate of the mobile phase was 0.256 mL/min. 
The injection volume was 75 µL and the column temperature was 35oC. Mass 
spectrometric measurements were performed with an electrospray ionization source 
operated in the positive ionization mode. High purity N2 was utilized for de-solvation and 
nebulization.  
 
 
Figure 3.3: Agilent 6230 TOF-LC/MS used for EE2 Analysis 
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Separation and detection of the pharmaceutical compounds was done using an 
Agilent 7890A GC-FID system (Figure 3.4). The GC-FID was equipped with a DB-5 
column (30 m x 320 µm x 0.25 µm).  Hydrogen was used as a carrier gas at 2.5 mL/min. N2 
was used as a make-up gas with a flow of 20.5 mL/min. Samples (1 µL) were injected in 
split less mode with a pressure pulse of 30 psi for 1.4 minutes. The injector was set as 250oC. 
The oven temperature was programmed as shown in Table 3.1. The FID was set at 310 oC. 
Table 3.1: Oven Temperature Program for GC analysis of Pharmaceuticals 
Rate oC/min oC Hold Time 
(min) 
Run Time 
(min) 
 0 60 1.5 1.5 
Ramp 1 20 120 0 4.5 
Ramp 2 4 160 0 19.5 
Ramp 3 12 300 3.8 30 
Figure 3.4: Agilent 7890A GC-FID System used for PhACs Analysis 
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3.6 Method Validation  
Sample extraction is a significant step; extraction recoveries of target compounds 
were calculated for spiked WWTP effluent and synthetic water samples at 3 concentration 
levels: 2.5, 5 and 10 µg/L. For the WWTP effluents, recoveries were determined relating 
the concentrations attained to the primary or initial spiking levels. In each case, samples 
were analyzed in triplicates. As the WWTP effluents included target compounds, blanks or 
un-spiked samples were analyzed and the measured concentrations were subtracted from 
those of the spiked samples. The method detection limit (MDL) for each compound was 
estimated from its concentration in spiked water samples after subjecting it to either SPE 
or LLE and reported as the minimum detectable concentration the compound with a signal 
to noise ratio of 3. The instrument detection limits (IDL) was calculated from the injection 
of a standard solution consecutively diluted until a concentration was reached that matched 
to a signal to noise ratio of 3.  
3.7 Preparation of Membranes  
Several batches of membranes were prepared in this study to establish the 
reproducibility of the performance of the membranes (see Appendix). Two principal types 
of membranes were prepared: a) Organic Solvent Nanofiltration (OSNF) membranes and 
b) Thin Film Composite (TFC) membranes. The OSNF membranes were prepared from 
RTV 615 and SYLGARD 184, using both commercially available PTFE ultrafiltration 
membrane and laboratory-made polysulfone (PSF) support as the base. In the case of TFC 
membranes interfacial polymerization was performed on a PSF support using m-
phenylenediamine (MPD) and trymesoyl chloride (TMC) with multi-walled carbon 
nanotubes (MWCNTs).  
3.7.1 Preparation of OSNF Membranes 
3.7.1.1 Preparation of the PDMS Coating Solution with RTV 615 
To prepare the PDMS coating solution, 5 g of RTV 615 pre-polymer (RTV-A) was 
dissolved in toluene to make a concentration of 15% (w/w). The mixture was placed on a 
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magnetic hot plate stirrer at a speed of 450 rpm and the temperature of the solution was 
brought to 60oC. At this point, the cross-linker, RTV-B (0.5 g) was added (RTV-A: RTV-
B = 10:1) to the solution under continuous stirring. This reaction was continued at 60oC in 
anticipation of the viscosity of the solution to be ~45 mPa-s. The viscosity was measured 
using Brookfield DV-II+ Pro, Programmable Viscometer. At this stage, toluene was added 
to dilute the concentration of RTV 615 down to 7.5%. The reaction again continued until 
the viscosity reached ~45 mPa-s. After that, toluene was added again to obtain final 
concentrations of RTV 615 of 5% and 2.5%, each with a viscosity of ~45 mPa-s. Once the 
desirable concentration and viscosity were achieved, the reaction was stopped by putting 
the solution into the ice-bath. Following the same procedure, another batch of PDMS 
solution was prepared using hexane as the solvent. 
 
Figure 3.6: Preparation of PDMS Coating Solution using RTV 615: the mixture was 
continuously stirred and heated at 60oC to get a homogeneous cross-linked solution 
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3.7.1.2 Preparation of the PDMS Coating Solution with SYLGARD 
184 
A 20% PDMS solution was prepared using SYLGARD 184 and hexane. The base 
and the hardener were mixed at a ratio of 10:1 [1] in hexane at 80oC. The solution was 
stirred continuously, maintaining the same temperature. Following the procedure in 
Section 3.7.1.1, the solution was diluted to 7, 5, 3.1, 2 and 1% SYLGARD 184. 
3.7.1.3 Preparation of the PSF Support 
In this case, a PSF support was first prepared using the phase-inversion technique. 
Exactly 20% (w/w) polysulfone (PSF) was dissolved in N,N’-dimethylformamide (DMF) 
to produce the casting solution [18]. This solution was cast on a clean glass-plate with a 
custom-made doctor-blade with a 200-µm slit. This liquid film was kept in air for about 
one minute to evaporate the solvent and then immersed in DI water to complete the phase-
inversion method. After 24 hours, the porous substrate was collected, dried in air and thus 
was ready to be used as a support. 
 
Figure 3.7: Custom-made Doctor Blade used to cast 20% PSF support membrane 
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3.7.1.4 Preparation of the Composite PDMS Membrane with RTV 
615 
Composite PDMS (RTV 615) membranes were prepared by using both 
commercially available PTFE membranes and the PSF supports prepared in this study. 
Both PTFE and PSF supports were dipped in the pre-crosslinked 7%, 5% and 2.5% PDMS 
solution made with toluene and hexane respectively for 30 secs. They were then taken out 
of the solutions very quickly with a tweezer by keeping track of time for consistent results. 
The coated membranes were then dried in air for 30 minutes to evaporate the solvent from 
the surface. Finally, the membranes were dried in an oven at 60oC for 4, 6 and 8 hours to 
complete the cross-linking reaction; the membranes were ready to use for the rejection and 
permeation tests (Figure 3.8) after the final cross-linking. 
  
Figure 3.8: 2.5% PTFE/PDMS (left) and 2.5% PSF/PDMS (right) membranes 
prepared in lab. The shiny surfaces prove the cross-linked PDMS layer on the 
supports. 
3.7.1.5 Preparation of the Composite PDMS Membrane with 
SYLGARD 184 
Commercially available PTFE membranes were dipped in pre-cross-linked 7, 5, 
3.1, 2 and 1% Sylgard 184 PDMS solutions for 30 seconds and then dried in the fume hood 
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for 30 minutes. The PDMS-dipped membranes were then dried in the oven at 80oC for 4, 
6, 8, 10, 12 and 18 hours to complete the cross-linking reaction. 
3.7.2 Preparation of Thin Film Composite Membrane 
For the purpose of uniform dispersion of MWCNTs in the PSF matrix, the 
MWCNTs were first modified. For the modification, 1 g of raw MWCNTs was soaked in 
100 mL solution of 3M HNO3: H2SO4 (1:3, v/v) and then was sonicated with a probe 
sonicator for 1 h. After that, the solution was refluxed at about 400 K for 12 hours following 
the study of Vatanpour et al. [19]. Then the solution was diluted with 2L of DI water and 
filtered through a 0.45µm filter. The modified MWCNTs were rinsed with DI water until 
a pH of ~7 was attained and were then put in the oven for complete drying. 
Asymmetric MWCNT/PSF support was prepared via phase-inversion technique 
[19, 20]. Exactly 20% (w/w) PSF was first dissolved into N,N’-dimethylformamide (DMF) 
to produce the casting solution [18] and then was left overnight to get rid of air bubbles. 
Dried and modified MWCNTs were then added to this polymer mixture to get a 1% 
MWCNT in the PSF support; the mixture was first stirred on a mechanical stirrer for 4 
hours and then sonicated for 30 minutes to get a good dispersion. Next, the solution was 
cast on a clean glass plate with the doctor blade, left in air for 1 minute and then immersed 
in DI water for 24 hours to complete the phase inversion technique.  
The active skin layer on the support was prepared by interfacial polymerization 
following the protocol of Xie et al. [21]: a 2% (w/v) m-phynylenediamine (MPD) solution 
was prepared in DI water. The MWCNT/PSF support was immersed in this MPD solution 
for 10 minutes and then the excess MPD solution was drained off. A rubber roller was used 
to remove the surplus MPD solution from the support. After that, the support was immersed 
in 0.1% trimesoyl chloride (TMC) in n-hexane solution for 10 secs, washed with 100 mL 
n-hexane and finally put in oven at 80oC for 10 minutes (Figure 3.9). 
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Figure 3.9: TFC membrane prepared on a support made with 0.1% modified 
MWCNTs and 20% PSF; the active skin layer is the result of the interfacial 
polymerization between 2% MPD and 0.1% TMC 
3.8 Characterization of Membranes  
Scanning Electron Microscopy (SEM) and Atomic Force Microscopy (AFM) were 
used to characterize the laboratory made OSNF membranes in the study. Morphology of 
the prepared membranes was examined using the Scanning Electron Microscopy apparatus 
(QuantaTM 3D FEG SEM, FEI Company, USA). Membranes for SEM imaging were 
prepared by immersing a sample of membrane in liquid nitrogen for several minutes. 
Frozen sample was subsequently fractured, sputtered with a thin layer of gold and 
subsequently analyzed with SEM technique. The gold layer contributed to improve 
conductivity of the sample surfaces and to achieve better quality of the data. Surface and 
cross section of membranes were scanned at various magnifications from 100 to 50,000. 
AFM technique was applied using a NanoScope MultiMode SPM System and NanoScope 
IIIa Quadrex controller, Veeco, Digital Instrument, UK. Surface analysis containing 
roughness determination was done by AFM images by tip scanning (tapping mode). 
Roughness of the surface (scanning sample size 5um x 5um) was shown as RMS - root 
mean squared roughness. During the measurements, silicon nitride (Si3N4) probes NP-1 
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(spring constant provided by the manufacturer (Veeco) 0.58 Nm-1) was applied. All tests 
were done under ambient conditions of temperature. 
3.9 Separation Performance of Membranes  
The filtration experiments were carried out using a stainless steel dead-end filtration 
system (HP4750, SterliTech Corp., USA). The schematic diagram of the filtration system 
is presented in Figure 3.10. The cell consists of a cylindrical stainless steel vessel with 
detachable end plates. A membrane sample was positioned at the end of the cell held by a 
porous stainless steel disk. The active area of the membrane inside the module was 14.6 
cm2 with a feed capacity of ~290 mL. The system was pressurized with compressed 
nitrogen gas. Each membrane was pre-compacted with DI water at a pressure of 5-30 bar 
until a constant flux was obtained. The flux through the membrane was calculated by the 
following equation: 
 
𝑱 =
𝑽
𝑨.𝑻
……………………………………. (3.1) 
Where J is the permeate flux (Lm-2h-1), V is the permeate volume (L), A is the 
membrane area (in m2) and T is the permeation time (h). The permeate volume was 
measured using a graduated cylinder.  
The pH of the feed solution was maintained at ~7.5. IBP, NPR and DCF with pKa 
values of 4.91, 4.15 and 4.15 respectively are deprotonated at pH 7.5 [22]. An initial 
volume of 270 mL feed with desired concentrations of pharmaceutical compounds was 
then passed through the membrane at 20-30 bar until a permeate of 120 mL and a 
corresponding retentate of 150 mL were collected. In the same manner, a feed of ~270 mL 
with desired concentrations of EE2 was passed through the membrane to get a permeate of 
~120 mL. The volume of permeate was measured with a graduated cylinder. The 
concentrations of pharmaceuticals in feed, permeate and retentate were analyzed using GC-
FID; while those of EE2 in feed, permeate and retentate were analyzed by LC-MS. The 
retention of pharmaceuticals and EE2 was calculated using Eq (3.2): 
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𝑹 =
𝐂𝐅−𝐂𝐩
𝐂𝐅
⋅ 𝟏𝟎𝟎………………………………… (3.2) 
Where, R is the % retention, CF is the concentration of solutes in feed and CP is the 
concentration of solutes in permeate. A mass balance was calculated using Eq. (3.3) by 
measuring the concentrations of the three pharmaceutical compounds and EE2 in the feed, 
permeate and retentate. 
Mass balance (% recovery) = 
𝑽𝑹.𝐂𝑹+ 𝑽𝑷  .𝑪𝑷
𝑽𝑭.𝐂𝐅
⋅ 𝟏𝟎𝟎…………………...……(3.3) 
Where, VR is the retentate volume, CR is the retentate concentration, VP is the permeate 
volume and VF is the feed volume. 
Figure 3.10: A Schematic Diagram of the Dead-End Filtration Set-Up 
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Chapter 4 
4 Results and Discussion 
This chapter presents and discusses the results of the experimental work carried 
out in the study. 
4.1 Extraction Recovery 
4.1.1 Recovery of Extracted PhACs 
Five-point calibration curves were generated for ibuprofen (IBP), naproxen (NPR) 
and diclofenac (DCF) within a concentration range of 1.25-50 µg/L using linear regression; 
the curves gave very good fits (R2>0.99) between peak area of the gas chromatographs and 
concentration (Figure 4.1A). The efficiency of the liquid-liquid extraction (LLE) was 
evaluated using recovery experiments. Recovery achieved for IBP, NPR and DCF ranged 
from 80 to 100% (Figure 4.1B, 4.1C, 4.1D). Compound recoveries were tested with water 
samples having pH between 1.95-3.6 and it was found that a pH of 1.95 showed the 
maximum recovery. The Method Detection Limit (MDL) for IBP, NPR and DCF was 0.1 
µg/L.  
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Figure 4.1: Recovery of ibuprofen, naproxen and diclofenac by Liquid-liquid 
Extraction. Figure 4.1A represents calibration curves obtained from LLE extracts 
of IBP, NPR and DCF. Figures 4.1 B, 4.1C and 4.1D represent the comparison 
between standards and extracts of IBP, NPR and DCF respectively.  
0
150
300
450
600
750
0 10 20 30 40 50 60
P
ea
k
 A
re
a
 o
n
 G
C
Concentration (µg/L)
Naproxen
Standard
Extraction
Average Recovery ~ 100%
(C)
0
150
300
450
0 10 20 30 40 50 60
P
ea
k
 A
re
a
 o
n
 G
C
Concentration (µg/L)
Diclofenac
Standard
Extraction
Average Recovery ~ 98%
(D)
83 
 
4.1.2 Recovery of Extracted EE2 
As in the case of the extracted PhACs, five-point calibration curves were also 
generated for EE2 using linear regression analysis and over concentration ranges of 0.019-
0.3 mg/L and 0.625-10 mg/L.; the curves gave very good fits (R2>0.99) (Figure 4.2A & 
4.2B). As most of the estrogenic compounds are moderately hydrophilic, polar solvents 
such as methanol and dichloromethane are widely used in their extraction [1-6]. The 
recovery of EE2 by SPE was tested for methanol, ethyl acetate, acetonitrile and 
dichloromethane and it was found that methanol gave the highest recovery of EE2 at 75% 
(Figure 4.3). Recovery achieved for EE2 through LLE was ~50%. MDL for EE2 was 50 
ng/L.  
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Figure 4.2: Calibration curves for EE2; A) Standards ranging from 0.019 to 0.3 mg/L 
(Top); B) Standards ranging from 0.625 to 10 mg/L (Bottom) 
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Figure 4.3: Recovery of EE2 during solid-phase extraction using methanol, ethyl 
acetate, acetonitrile and dichloromethane as elution solvent. Methanol shows 75% 
recovery which is the highest among other elution solvents. 
4.2 Concentrations of IBP, NPR, DCF and EE2 in 
Wastewater Effluent 
There are six wastewater treatment plants (WWTPs) in London, Ontario, all 
operated by the City of London and located along the Thames River. The estimated 
population size served by the Adelaide WWTP is 85,183; while that of the Greenway 
WWTP is 175,517 based on census data and the sewersheds.  The Greenway plant receives 
about 60% of the flow generated in London as well as the thickened sludge from all the 
satellite plants for processing in centrifuges and for incineration.  The Greenway facility 
also receives wastes from three major hospitals, food processing plants, platers, etc.  The 
Adelaide plant receives sewage from the north-east part of the City which is mainly 
residential and commercial. To eradicate solids in these WWTPs, screens and settling tanks 
are used. Solids that fail to pass through the screens are removed and landfilled, whereas 
suspended solids are removed in large settling tanks during “Primary Treatment”. In the 
case of “Secondary Treatment”, bacteria and other micro-organisms are grown and aid in 
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the removal of organic material and transformation of ammonia to nitrate. This process 
takes place in the aeration section in the presence of oxygen. The effluent from the aeration 
tank is passed to a final tank; here suspended sludge (waste solids and bacteria) settle out 
by gravity and are removed. In order to remove phosphorous, chemicals are utilized. 
Subsequently, the sludge is pumped to centrifuges, dewatered and incinerated. To end with, 
for the purpose of disinfection, ultra-violet light is used and the disinfected water is then 
released to the Thames River.  
Figure 4.4 shows a schematic diagram of the Activated Sludge Process used in 
WWTPs in London, ON and Table 4.1 shows the capacity, actual flow and sludge 
production of the WWTPs. 
 
 
Figure 4.4: Different steps of Activated Sludge Process followed in treating 
wastewater in different WWTPs in London, ON. (City of London, March 2013) 
 
87 
 
Table 4.1: Capacity, Actual Flow and Sludge Production of the WWTPs in London, 
Ontario (City of London, March 2013) 
WWTP Capacity (m3/day) 2013 Actual Flow 
(m3/day) 
Sludge produced average day 
(m3) (normalized to 3% solids) 
Adelaide 36,400 25,800 325 
Greenway 152,175 129,900 1,180 
Oxford 17,250 9,900 101 
Pottersberg 39,100 27,000 216 
Southland 564 286 1 
Vauxhall 20,900 15,800 111 
Total 266,389 208,686 1,934 
 
It has been reported that NPR exists in WWTP influents in the range of 1.14-52.9 
µg/L [7], in the  effluents in the range of 0.1-5.09 µg/L [7-10] and 0.01-0.1 µg/L in surface 
waters [9, 11, 12]. For IBP, concentrations in WWTP influents and effluents are 3.73 – 603 
µg/L and 1.3-10.16 µg/L [7, 10]. According to Tixier et al. [10], the effluent of a WWTP 
in Switzerland showed the existence of DCF to be 0.99 µg/L. Santos et al. [13] analyzed a 
number of influent and effluent wastewater samples collected from four different WWTPs 
located in Seville city, Spain. According to this study, the mean amount of IBP, and NPR 
in effluent wastewater was in the range of 4.13-10.16 µg/L and 1.64-2.74 µg/L, 
respectively. Yang et al. [14] reported 220 ng/L of DCF and 11 µg/L of IBP in the primary 
effluent of an advanced wastewater reclamation plant in Gwinnett County, Georgia, U.S.A. 
Wastewater effluents collected from Beggen, Luxembourg, showed maximum 
concentration of IBP and DCF to be 359 and 78 ng/L, respectively [15]. Metcalfe et al. 
[16] collected influent and effluent samples from 18 sewage treatment plants in 14 
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municipalities in Canada. The concentrations of IBP and NPR ranged 1- 24.6 µg/L and 7.2 
- 33.9 µg/L respectively in the effluent samples. DCF, on the other hand, was found in only 
one WWTP influent at a concentration of 1.3 µg/L [16].  
An analysis was done by Ternes et al. [17] on different STP effluents in Canada, 
Brazil and Germany. The results indicated an EE2 concentration of 9 ng/L in the effluents 
of Canada which is higher than that of in Germany (1 ng/L). Wastewater samples collected 
from Cornwall WWTP, Ontario, Canada, contained 9.8 ng/L of EE2 [18]. In one research 
work by Fernandez et al.[19] it was shown that EE2 was the most recurrently spotted 
synthetic estrogen in municipal effluents in Western Canada; nevertheless, its 
concentration was as low as 5 ng/L with some irregular occurrences of up to 178 ng/L.  
Research done on the effluent of the municipal WWTP in Brandon, Manitoba, Canada, 
indicated the presence of EE2 at a concentration of 7.63 ng/L after UV-treatment [20]. In 
a study of  WWTPs in Calgary, Alberta, Chen et al. [21] reported an EE2 concentration of 
8.5 ng/L. Lishman et al. [22] studied the occurrence of pharmaceutical and personal care 
products along with estradiol and estron in 12 Ontario Municipal WWTPS discharging into 
the Thames River; however, EE2 was not included in that study. Another survey conducted 
on the effluents of several STPs in Germany showed EE2 concentrations of 3-13 ng/L, 
while river waters revealed a maximum concentration of 1.6 ng/L [23]. Some river water 
samples collected from Italy showed E1, E2 and EE2 concentrations of 0.04-1.5 ng/L [24]  
whereas in the UK, the EE2 concentrations in river waters were in the range of 0.4 to 3.4 
ng/L [25].  EE2 has been detected in drinking water (Germany) at a concentration of 0.5 
ng/L [26]. Table 4.2 shows EE2 concentrations in WWTPs influents, WWTPs effluents 
and in surface water in a number of countries.  
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Table 4.2 Concentrations of EE2 in influents and effluents of WWTPs as well as in 
surface water [18, 27] 
Country EE2 concentration (ng/L) 
France Influent: 4.9-7.1 
Effluent: 2.7-4.5 
Surface water: 1.1-2.9 
USA Influent: 0.1-4.3 
Effluent:<0.02-0.76 
Surface water:<0.02-0.52 
Italy Influent:<1.6 
Effluent:<1.1 
Surface water:<0.4-1.0 
Ontario, Canada Influent: 5.7 (The City of Cornwall WWTP) 
Effluent: 9.8 (The City of Cornwall WWTP) 
Surface water: 2.2 (Ottawa River) 
 
Tables 4.3 and 4.4 show the amount of IBP, NPR, DCF and EE2 identified in the 
wastewater effluents of Greenway and Adelaide Treatment Plants during this research 
work over a period of 6 months.  
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Table 4.3: IBP, NPR and DCF in Greenway Pollution Control Plant  
 
 
 
 
 
 
 
 
 
Table 4.4: IBP, NPR, DCF and EE2 in Adelaide Wastewater Treatment Plant 
 
 
 
 
 
 
 
 
 
Date of 
sample 
collection  
IBP (µg/L) NPR (µg/L) DCF (µg/L) 
31-Aug-15 0.66 2.09 0.45 
18-Sep-15 <LOD 1.22 0.45 
31-Oct-15 2.26 1.46 0.49 
20-Nov-15 3.63 8.98 0.73 
08-Dec-15 2.78 4.78 1.23 
29-Jan-16 3.31 5.09 1.04 
Date of 
sample 
collection  
IBP (µg/L) NPR (µg/L) DCF (µg/L) EE2 (µg/L) 
31-Aug-15 1.88 2.85 0.29 <DL 
17-Sep-15 0.98 1.42 0.47 <DL 
30-Oct-15 2.37 2.14 0.52 <DL 
21-Nov-15 <LOD 3.62 0.48 <DL 
07-Dec-15 2.85 3.64 0.46 <DL 
31-Jan-16 3.32 2.98 0.42 <DL 
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It can be seen that the occurrence of IBP in the effluent of Greenway Pollution 
Control plant varied between 0.66 to 3.63 µg/L; whereas the concentration ranged between 
0.98 to 3.32 µg/L in case of Adelaide Wastewater Treatment Plant. The presence of NPR 
in the effluents of both WWTPs varied from 1.22 to 8.98 µg/L. On the other hand, the 
amount of DCF determined in the effluents of Greenway ranged between 0.45 and 1.23 
µg/L and, in the case of Adelaide, it was between 0.29 and 0.52 µg/L. Therefore, it can be 
concluded that the results support quite well what has been reported in literature [8, 11, 28, 
29]. Nonetheless, the pattern of usage as well as the removal efficiency of these drugs may 
also fluctuate throughout the year, resulting in variability in the concentrations of PhACs 
within the watershed. It should be noted that in our research, we did not find any EE2 in 
the Adelaide WWTP effluent; this could be explained by the fact that EE2 might be below 
the detection limit (MDL 50 ng/L) of the LC-MS method used in this study.  
4.3 Preparation of PDMS Coating Solution 
The preparation of thin membranes is of utmost importance because the thickness 
of the membranes controls the flux through it. A good quality composite membrane is 
fabricated only when the PDMS coating solution has well-defined properties, like adequate 
concentration and viscosity. It has been found that a higher concentration and higher 
viscosity of the coating solution make the PDMS layer thick, whereas a lower viscous 
solution results in high pore intrusion and defects [30]. To make a thin, selective layer, the 
viscosity of the PDMS solution should be high and the concentration low [30]. Therefore, 
it is desirable to pre-cross link the PDMS solution containing lower concentration [31]. 
Dutczak et al. [30] used a 3.75% (w/w) PDMS toluene solution with a viscosity of 55 mPa-
s to prepare a composite capillary membrane that showed the highest toluene permeance 
and low pore intrusion. For that purpose, in this study, first a 15% PDMS coating solution 
was prepared, pre-crosslinked and eventually was diluted to get concentrations of 7.5%, 
5% 2.5 % when using RTV 615 and 7, 5, 3.1, 2 and 1% when using SYLGARD 184 as 
PDMS. It has been found that the PDMS solutions of concentrations 5~7.5% resulted in 
membranes that were very tight and almost impermeable. On the other hand, 
concentrations as low as 1.85-2.5% with a viscosity of ~45mPa-s formed the best 
membranes. Figure 4.5 shows the difference in permeability between 2-2.5% PDMS 
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membranes, due to a difference in viscosity of the coating solution. When the viscosity of 
the PDMS solution was increased from 20 mPa-s to 45 mPa-s, the permeability of the 
membrane almost doubled. These results support the study of Dutczak et al. [30].  
 
Figure 4.5: Difference in membrane permeability due to change in viscosity of PDMS 
coating solution. Higher viscosity causes higher permeability.    
 
The pre-crosslinking temperature was maintained at 60oC following the study of 
Dutczak et al. [30] because if the temperature is below 50oC, the viscosity stays below 20 
mPa-s for more than 300 min. This was also proved in trial experiments in our work.  
The cross-linking temperature in the oven was maintained at 60oC and the time for 
cross-linking was optimized to be 4 hours for RTV 615. It has been found in this study that 
the more the cross-linking time exceeds 4 hours for RTV 615, the tighter the membrane 
becomes and the lower the permeability. Figure 4.6 shows the volume of permeate 
monitored for three 1.85% PDMS (RTV 615) membranes (cross-linked at different 
temperatures) when the pressure was 10 bar. It can be seen that the maximum volume of 
permeate (96 mL) was achieved when the membrane was cross-linked for 4 hours whereas 
0
5
10
15
20
25
30
5 10 20 30
F
lu
x
 (
L
/(
m
2
-h
)
Pressure, bar
2.5%
(20mPa-s)
2.5%
(45mPa-s)
93 
 
a cross-linking of 8 hours gave the minimum permeate volume (15 mL) at the end of ~90 
minutes. 
 
Figure 4.6: Comparison of Permeate Volume at Different Cross-linking Temperature 
However, in case of SYLGARD 184, the cross-linking process took a longer period, 
~18 hours. This might be due to the usage of 10 gm clips of SYLGARD 184. The package 
contained pre-measured base and hardener (10:1) from the supplier, which gave 
inconsistent cross-linking throughout the study period.  
4.4 Characterization of NF Membranes 
4.4.1 SEM Characterization 
Figure 4.7 shows the SEM photomicrographs of 2.5% PTFE/PDMS composite 
membrane. Figure 4.7A presents the cross-section and it is evident from the SEM image 
that the PDMS top layer is tightly and properly cast on top of the PTFE support. Figure 
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4.7B and 4.7C show the top surfaces of PTFE/PDMS membranes made from coating 
solutions with viscosity ~45 mPa-s and 15 mPa-s respectively; the polymer clusters or 
crystals on the top surface in Figure 4.7c is formed due to the low viscosity of the PDMS 
(~15 mPa-s).  
 
   
(B) 
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Figure 4.7: SEM photographs of 2.5% PTFE/PDMS composite membrane: a) cross-
section (~45 mPa-s); b) top surface (~45 mPa-s); c) top surface (~15 mPa-s) 
 
4.4.2 AFM Characterization 
Figure 4.8 shows the AFM photographs of three PTFE/PDMS membranes and a 
thin film composite (TFC) membrane: Figure 4.8A represents PTFE/PDMS prepared with 
PDMS (RTV 615) solution with a viscosity of ~45 mPa-s; this membrane was not 
compacted under pressure. Figure 4.8B shows a TFC membrane prepared with 2% MPD, 
0.1% TMC and 0.1% CNT on a 20% PSF support. It has been stated by researchers that 
the introduction of hydrophilic functional groups into the surface of CNTs enhances the 
dispersion of CNTs into a particular polymer matrix [32]. The use of functionalized carbon 
nanotubes could increase the hydrophilicity and surface charge of the membrane’s top layer 
which eventually enhances the property of NF membranes by providing better resistance 
to fouling and improved salt rejection [32]. In Figure 4.8B, the dispersed MWCNTs is clear 
in PSF matrix showing very good bonding of the acid modified MWCNTs in the PSF 
(C) 
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matrix. Figure 4.8C represents a used PTFE/PDMS membrane with PDMS 45 mPa-s 
whereas Figure 4.8D shows a PTFE/PDMS membrane prepared with a PDMS solution of 
~15 mPa-s, used. It is clearly evident that the membrane prepared with a lower viscosity 
PDMS solution shrinks more than that prepared with a more viscous PDMS solution.  
 
(A)                                                                         (B) 
   
 (C)      (D) 
Figure 4.8: SEM images of different NF membranes: A) 2.5% PTFE/PDMS 
(unused, not compacted); B) 2% MPD, 1% TMC and 0.1% MWCNT on 20% PSF 
support; C) 2.5% PTFE/PDMS (viscosity ~45mPa-s); D) 2.5% PTFE/PDMS 
(viscosity ~15mPa-s). 
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4.5 Permeability Performance of NF Membranes 
4.5.1 Permeability Performance of PTFE/PDMS (RTV 615) 
The filtration performance of composite PTFE/PDMS membrane in water has been 
investigated including the effect of transmembrane pressure. Figure 4.9 presents the effect 
of the operating pressure (5, 10, 20 and 30 bars) on the volume of permeate passing through 
a PTFE/PDMS composite membrane with PDMS concentration of 2.5%, having a 
viscosity of ~ 45 mPa-s. The volume of permeate increased with increasing pressure, which 
indicates no compaction of membrane occurred over the applied pressure range. Figure 
4.10 represents the flux of 2.5% PDMS (45 mPa-s) at different pressures.  
 
Figure 4.9: Influence of Pressure on volume of permeate for 2.5% PTFE/PDMS (RTV 
615) Membrane 
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Figure 4.10: Flux at different pressures for 2.5% PTFE/PDMS (RTV 615) membrane. 
With an increase of pressure, flux increases. 
The permeability of the 2.5% PTFE/PDMS membrane was compared with that of 
DuraMem, a commercially available OSNF membrane, prepared with modified polymer. 
Figure 4.11 shows the influence of pressure (10, 20, 30 & 40 bars) on flux for DuraMem, 
over a period of 2.5 hours. The results show that this membrane was also not compacted 
over the applied pressure range. Figure 12 reflects the flux through DuraMem membrane 
at different pressures. and if compared with Figure 4.10, it can be seen that the flux through 
the laboratory made PTFE/PDMS is higher than that of the commercially available 
DuraMem membrane.  
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Figure 4.11: Influence of Pressure on Flux for Commercial DuraMem Membrane 
 
Figure 4.12: Flux at different pressures for commercial DuraMem membrane 
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4.5.2 Permeability Performance of PTFE/PDMS (SYLGARD 184) 
When the PDMS solutions were prepared from SYLGARD 184 (15%, 7%, 3.1%, 
2%, 1%), it was found that 15% and 7% resulted in very tight NF membranes whereas 1% 
(Figure 4.13.A), 2% (Figure 4.13.B) and 3.1% (Figure 4.13.C) solutions were successfully 
tested to check the permeability at 10, 20, 30 and 40 bars. It is evident from Figure 4.13 
that with a decrease in PDMS concentration, permeability increases; 3.1% gives the lowest 
permeate volume (120 mL) and 1% shows the highest permeate volume of 450 mL after 2 
hours of operating. 
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Figure 4.13: Influence of pressure on flux for SYLGARD 184 PTFE/PDMS 
membrane: A) 1% PTFE/PDMS; B) 2% PTFE/PDMS; C) 3.1% PTFE/PDMS 
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The SYLGARD 184 PTFE/PDMS was compacted when the applied pressure 
exceeded 30 bars; the result was consistent when the Flux versus Pressure values for 3.1, 
2 and 1% SYLGARD 184 PTFE/PDMS membranes were compared (Figure 4.14). 
Nevertheless, in this case also, the permeability was lower than that of the PTFE/PDMS 
made from RTV 615. Thus it can be stated the PTFE/PDMS composite membrane prepared 
from 2.5% RTV 615 with a viscosity of ~ 45 mPa-s (Figure 4.10) showed the highest flux 
among all the OSNF membranes. 
 
Figure 4.14: Flux (mL/min) at different pressures for 3.1%, 2% and 1% PTFE/PDMS 
membrane made from SYLGARD 184. 
 
4.6 Removal of PhACs using different types of NF 
Membranes 
The transport mechanism of organic solutes through NF and RO membranes has 
attracted the attention of several researchers. It is very important to understand the retention 
mechanism of the trace contaminants in the nanomembrane as well as their chemical 
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characteristics and environmental fate in order to design a suitable treatment system. The 
separation through the nanomembrane can be achieved by physical selectivity (charge 
repulsion, size repulsion, size exclusion or steric hindrance) or chemical selectivity 
(solvation energy, hydrophobic interaction or hydrogen [33-41]. Size exclusion is an 
important phenomenon showing that suspended particles larger than the pore sizes of the 
membrane get trapped on the surface of the membrane as wastewater passes through. This 
can be compared to sieving phenomenon except that neither the solute has uniform size nor 
the membranes possess uniform pores [36, 37, 42]. Pore size, molecular size and pure water 
flux are found to be useful for predicting solute retention. When the membrane pores are 
larger than the size of trace contaminants, surface diffusion becomes faster than sorption 
diffusion [35, 36]. Another important removal mechanism is adsorption and subsequent 
sorption diffusion which is the initial stage in the transport mechanism of organic molecule 
using NF. Measurement of the hydrophobicity is done through LogKow i.e. partitioning 
between octanol and water. Trace contaminants with high LogKow or high hydrogen 
bonding capacity get adsorbed to the membrane surface [36]. The capability to form 
hydrogen bonding with hydrophilic groups of membrane polymer regulates the water flow 
through the membrane, whereas adsorption caused by hydrogen bonding can lessen water 
infiltration [36]. Compounds with no hydrogen bonding capacity are reported to exhibit 
significant adsorption and negligible water flux drop whereas compounds with high 
hydrogen capacity promotes significant drop in flux [36]. The electrostatic and steric 
hindrance have significant involvement in the solute retention, which is a function of the 
ratio of charge density of membrane to ionic concentration, solute radius to pore radius of 
membrane as well as relative mobility between cations and organic anions [36]. In other 
words, it can be revealed that pH and ionic strength can be expected to be influential factors 
in the retention of organic molecules.  Various researchers have reported an increase in the 
rejection of negatively charged organic solutes owing to electrostatic repulsion among the 
negatively charged membrane and the negatively charged organic solute [38, 43-46]; 
however, organics that are positively charged show reduced retention on negative 
membranes [36]. At high pH, the adsorption is lower because of charge repulsion [37]. 
With a variation in pH, the zeta potential of the membrane diverges from positive to 
negative along with dissociation of the functional groups of membrane polymers taking on 
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positive or negative charge fractions [33, 36]. When the NF membranes are considered to 
be “tight”, then the rejection of polar trace contaminants might be dominated by a size 
exclusion/steric hindrance mechanism [47]. 
There is a general lack of good understanding of the fundamental transport 
mechanisms for both solute and solvent in the OSNF system, through dense or porous 
structure [48, 49]. According to some researchers, the solution-diffusion process is the 
mechanism of transport through OSNF [50-52]. This model describes the transport 
mechanism through a polymer film as a composition of three main steps: sorption, 
diffusion and desorption [49]. Whereas others have advocated a convective mechanism, 
based on several specific fluid dynamic laws, as the explanation for transport through 
porous media [53-55]. Soltane et al. [49] invoked the Hagen-Poiseuille Law as the most 
likely explanation, wherein it is assumed that the membrane is made of cylindrical pores. 
Besides, the Spiegler-Kedem-Katchalsky model is a hybrid model in which the membrane 
is considered to be a “black box” and the solvent and solute fluxes are expressed separately 
[56]. Soltane et al. [49] worked specifically on solute transport processes in OSNF 
mechanism by describing solvent-membrane affinity, solvent-solute affinity and solute-
membrane affinity; they predicted through the concept of solubility parameter theory by 
Hansen. According to Hansen’s solubility parameter theory, the solubility parameter 
describes the density of cohesive energy and comprises three different types of interactions: 
hydrogen bonding interaction (𝛿𝐻), polar interaction (𝛿𝑃) and dispersion interaction (𝛿𝐷) 
[57]. The total solubility parameter 𝛿𝑇 , can be expressed as: 
 
𝛿𝑇
2  =  𝛿𝐻  
2 + 𝛿𝑃 
2 + 𝛿𝐷
2………………………………… (4.1) 
 
The more comparable the solubility parameters of two molecules are, the more 
imperative is their affinity and the more they can be conjointly soluble. In consequence, 
the absolute difference in solubility parameter of two molecules allows for the evaluation 
of a qualitative assessment of the strength of their attraction. If δA and δB are solubility 
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parameters of molecules A and B respectively, then the absolute difference in their 
solubility parameter is |𝛿𝐴 − 𝛿𝐵|; the higher the |𝛿𝐴 − 𝛿𝐵| value, the lower their mutual 
affinity [49]. 
In the present study, OSNF with a PTFE support and a 2.5% PDMS top-coating has 
been used to assess the retention capacity of the membrane for IBP, NPR and DCF from 
aqueous media. The solubility parameters for the pharmaceutical compounds, water and 
PDMS membrane are given in Table 4.5. Since an established universal model for the 
solute transport in OSNF membrane does not exist, an experimental approach by Soltane 
et al. [49] was followed in this study to analyze the effects of solute sorption/ diffusion 
through the PDMS membrane. For the purpose of a better understanding of solute transport 
through PDMS membranes, various interactions such as, solvent membrane affinity, 
solvent-solute affinity and solute membrane affinity were considered. 
Table 4.5: Solubility parameters of pharmaceutical compounds, water and PDMS 
Compounds Solubility Parameter δ 
(MPa)1/2 
Reference 
IBP 20.9 [58] 
NPR 23.4 [58] 
DCF 27.79 [59] 
Water 47.81 [57] 
PDMS 16.42 [57] 
 
Figure 4.15 illustrates the rejection capacity of the 2.5% PDMS membrane for the 
study pharmaceuticals, IBP, NPR and DCF. The results show that this particular PDMS 
membrane was able to reject 64% IBP, 65% NPR and 70% DCF. The graph also includes 
the values of solute - membrane affinity (on top) and solute-solvent affinity (at the bottom) 
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for each of the pharmaceuticals. According to this graph, DCF has the lowest solute 
membrane affinity, 11.37 MPa½ while IBP has the highest value, 4.48 MPa½. According to 
Soltane et al. [49], the solute membrane affinity seems to have a significant effect on the 
separation mechanism: the higher the interaction, the lower the rejection. This supports 
rejection results in the present study: DCF showed the highest rejection when compared to 
IBP and NPR. Then again, the higher the affinity of the solute with the solvent, the more 
significant the rejection of the solute is: this is also supported by our results since IBP has 
the lowest solute-solvent affinity and the lowest rejection. 
 
Figure 4.15: % Removal of pharmaceuticals by 2.5% PTFE/PDMS (RTV 615) 
membranes 
Another set of experiments were performed to see the effect of base support of a 
2.5% PDMS membrane on removal efficiency of IBP, NPR and DCF. The first membrane 
contained 2.5% PDMS active layer on commercially available PTFE support and the 
second membrane possessed 2.5% PDMS active layer on a laboratory made 20% PSF 
support. From Figure 4.16, it can be seen that change of support did not greatly affect the 
removal efficiency of the membrane. That means the composite membrane, prepared in the 
laboratory by casting PSF support and top-coating with PDMS solution was as efficient as 
the composite membrane prepared by using commercially available PTFE support. Figure 
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4.17A and 4.17Bb show the similarity in structure of a commercial PTFE support along 
with a hand- cast PSF support. 
 
Figure 4.16: Comparison of pharmaceutical removal capacity of 2.5% PDMS 
membrane having PTFE and PSF support 
  
(A)     (B)  
Figure 4.17: SEM of (A) Commercial PTFE support (left); B) PSF support cast in lab 
(right) 
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The TFC membrane prepared in lab with 2% MPD, 0.1% TMC and 0.1% CNT on 
a 20% PSF support was also used to check the removal capacity for IBP, NPR and DCF 
and it was found that IBP was removed 60%, NPR 56% and DCF 66%. In literature, it has 
been mentioned that commercial NF membranes are able to remove ~ 99% of PhAcs; 
however, the actual composition of those NF membranes are not mentioned anywhere. 
 PTFE/PDMS membranes prepared with 3.1%, 2% and 1% SYLGARD 184 were 
used for removing pharmaceuticals and it was found that 3.1% PTFE/PDMS showed the 
lowest removal efficiency whereas 2% PTFE/PDMS performed the best (Figure 4.18).  
 
Figure 4.18: Removal efficiency of 3.1%, 2% and 1% PTFE/PDMS (SYLGARD 184) 
membranes  
When commercial DuraMem membrane was used, the removal for IBP, NPR and 
DCF was 48.6%, 45.4% and 58.12%, respectively. Thus it can be seen that the 2.5% 
PTFE/PDMS (RTV 615) is better than the Commercial DuraMem membrane from the 
perspective of both permeability and removal of pharmaceuticals. Figure 4.19 shows a 
comparison between the four types of membranes used in this study for the removal of IBP, 
NPR and DCF. It is clear that the composite PTFE/PDMS prepared with RTV 615 gives 
the best result among all the membranes. Therefore, the PTFE/PDMS (RTV 615) 
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membrane was subsequently used to evaluate the rejection capacity of EE2 in the next 
section. In all cases, the mass recovery of pharmaceutical compounds was found to be 
between 93~100%. 
 
Figure 4.19: Comparison of removal efficiency of IBP, NPR and DCF: DuraMem, 
PTFE/PDMS (RTV 615), PTFE/PDMS (SYLGARD 184) and TFC  
4.7 Removal of EE2 using PTFE/PDMS Membranes 
Researchers have found that low molecular weight volatile compounds usually face 
low retention on NF membranes and branched and complex molecules get rejected by RO 
membranes [36, 37]. As the molecular weight of EDCs vary between 268 and 315 g/mol 
[37], they are found to be too small to be retained on MF or UF membranes and are 
expected to show higher retention on NF and RO membranes [37]. Neutral organic solutes 
have been known to be rejected by steric hindrance effect/ size exclusion between the 
solutes and the membrane polymeric matrix [21, 60-63].  According to Nghiem et al. [45], 
natural steroid hormones are known to partition onto the membrane and successively 
diffuse through the membrane polymer which results in lower removal of trace 
contaminants when compared to that through size exclusion mechanism. EDCs with 
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LogKow > 2.5 are anticipated to interact with the membranes by hydrophobic interactions 
[37]. 
Most of the available commercial NF membranes are thin-film composite (TFC) 
membranes where an ultra-thin (10 nm to several µm) dense layer (top selective layer) is 
formed on a bottom porous substrate by interfacial polymerization [64-68]. TFC-S, TFC-
ULP, TFC-SR1, TFC-SR2 are some examples of commercial polyamide on polysulfone 
membranes that were found effective in removing estrone [33, 49] and estradiol [36]. 
Bodzek and Dudziak [69] used two types of flat membranes-NF polyamide and NF 
cellulose in conjunction with coagulants and found removals of almost 94% EE2, 92% 
estradiol & estron and 82% estriol. NF90, another commercial NF membrane, succeeded 
in removing approximately 90% of EE2 whereas a different membrane, NF200, could 
remove ~75% EE2 [70]. Estrone, estradiol, testosterone and progesterone were almost 
completely retained on NF270 and NF90 in a research work by Ngheim et al. [36].  EE2 
rejection of about 90% and 98% retention of progesterone were observed by using NF200 
by Koyunchu et al. [71]. In another study, NF 270 showed the highest retention of micro 
pollutants when a synthetic urine sample was tested [46].  
 In the present study two identical PTFE/PDMS membranes were used to 
check EE2 removal efficiency; both were prepared with 2.5% PDMS (RTV 615) solution 
having a viscosity of ~45 mPa-s cast on a commercial PTFE membrane. For Membrane 1, 
a feed concentration of 66 µg/L and for Membrane 2 a feed concentration of 19 µg/L were 
used. In both cases, triplicate samples were analyzed for accuracy. It was found that the 
removal efficiency of 2.5% PTFE/PDMS (RTV 615) membrane ranged between 95~97% 
(Table 4.6). The removal mechanism can be explained by size exclusion theory- both the 
EE2 and the PTFE/PDMS membrane have neutral surface and since EE2 has a small 
molecular weight, it gets trapped on the surface of the PDMS membrane. As a result, almost 
3-5% of EE2 remained in the permeate solution when the feed solution is passed through 
a dead-end filtration system. 
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Table 4.6: Removal of EE2 with 2.5% PTFE/PDMS Composite Membrane 
 
2.5% PTFE/PDMS 
(RTV 615) 
 
Feed (µg) Permeate (µg) % Removal  
Membrane 1 18.05 0.55 97% 
Membrane 2 5.28 0.27 95% 
 
4.8 Conclusions 
After analyzing the wastewater effluents from Adelaide Wastewater Treatment 
Plant and Greenway Pollution Control Plant, over a period of six months, it has been found 
that samples contained IBP, NPR and DCF in very small concentrations, 0.66 ~ 3.63 µg/L, 
1.22 to 8.98 µg/L and 0.29 to 1.23 µg/L respectively, supporting the previous research 
works.  The presence of EE2 in the effluents of Adelaide Wastewater Treatment Plant could 
not be detected, considering the concentration was below the detection limit of the 
analytical instrument.  
While preparing PTFE/PDMS composite membranes using RTV 615, it could be 
concluded that the process of pre-crosslinking was necessary to get a PDMS solution of 
low concentration and high viscosity because PDMS solutions with higher concentrations 
and lower viscosity declined the permeability of the membranes. The optimal condition 
was, therefore, pre-crosslinking of a 2.5% PDMS (RTV 615) solution at 60oC until a 
viscosity of ~45mPa-s is achieved. The most appropriate duration of final cross-linking 
was found to be 4 hours.  However, when SYLGARD 184 was used as PDMS solution, 
the final cross-linking time extended up to 18 hours.  
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Along with PTFE/PDMS (RTV 615) and PTFE/PDMS (SYLGARD 184), a 
commercial OSNF membrane, DuraMem, was also tested for membrane permeability as 
well as removal efficiency of PhACs. It has been found that all of the membranes showed 
a linearity between flux and pressure within a pressure range between 5~30 bars. Besides, 
a TFC membrane was prepared and tested as well to check its pharmaceutical removal 
efficiency. It was found that 2.5% PTFE/PDMS (RTV 615, viscosity ~45 mPa-s) showed 
the best performance in case of both permeability and removal efficiency of IBP, NPR and 
DCF. Therefore, this membrane was tested for rejection of EE2 and was found that the 
membrane could successfully remove 95-97% EE2. 
 
The retention mechanism of OSNF for pharmaceuticals has been explained by 
solution-diffusion mechanism based on Hansen’s Solubility Parameter Theory; whereas 
EE2 was considered to be removed through OSNF following size exclusion mechanism of 
NF membranes. 
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 Chapter 5 
 
5 Summary and Conclusions  
The incomplete removal of pharmaceutically active as well as endocrine disrupting 
compounds through conventional wastewater treatment plant results in their occurrence in 
the aquatic environment. Even a very small amount of these compounds may have potential 
negative impacts on human and ecosystem health. For example, long term exposure to EE2 
in the aquatic environment may result in the creation of female-specific protein in male 
fish, introduction of gonopodia in female, lower sperm count as well as incidence of 
intersexuality. On the other hand, the absence of strict procedures precise to these trace 
contaminants along with insufficient protections and monitoring guidelines has made 
analysis of these compounds very important. 
In this work, wastewater effluents were collected from two major wastewater 
treatment plants in London, ON, Canada: Adelaide Wastewater Treatment Plant and 
Greenway Pollution Control Plant. Necessary sample preparations were made and 
individual analytical methodologies were developed to analyze the collected effluents for 
the identification and quantification of ibuprofen (IBP), naproxen (NPR), diclofenac (DCF) 
and 17α-ethinylestradiol (EE2) on GC-FID and LC-MS. It was found that the wastewater 
effluents contained IBP in the range of 0.66-3.63 µg/L, about 1.22 to 8.98 µg/L of NPR 
and DCF within a limit of 0.29 to 1.23 µg/L. However, the presence of EE2 in the effluent 
was below the detection limit (50 ng/L) of the LC-MS.  
Although physico-chemical transformation processes like photolysis, ultra violet 
irradiation, oxidation, ozonation and hydrolysis are being used to treat water contaminated 
with trace amounts of PhACs and EE2, it is possible that the compounds are not completely 
mineralized forming intermediates and by-products due to their low biodegradability, high 
water solubility, elevated chemical stability and decreased tendency for sorption. In this 
study, a novel approach has been presented for the removal of PhACs and EE2 from water 
using organic solvent nanofiltration (OSNF) membranes. OSNF membrane technology is 
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an energy competent separation process that has been successfully used to remove 
molecules of 200-1,000 g/mol in several organic solvents. OSNF membranes are 
asymmetric, integrally skinned, or composites containing a thin poly (dimethyl siloxane) 
(PDMS) layer on a porous support. In this study, instead of using an organic solvent, the 
OSNF was used in aqueous media.   
As a part of the removal of PhACs and EE2, in this study, customized composite PDMS 
membranes were prepared using both commercial PTFE ultrafiltration membrane and 
laboratory made polysulfone (PSF) ultrafiltration membrane as base support; RTV 615 and 
SYLGARD 184 served as PDMS solutions to create an active skin layer on the polymeric 
supports. Along with that, a thin film composite (TFC) nanomembrane was also 
synthesized where the base support was made with a homogeneous mixture of PSF and 
multi-walled carbon nanotubes (MWCNTs) and the thin active layer on top of the support 
was prepared through interfacial polymerization between m-phenylenediamine (MPD) and 
trimesoyl chloride (TMC). These lab-made composite membranes were subsequently 
investigated for the purpose of membrane performance and removal of IBP, NPR, DCF 
and EE2. Furthermore, a commercially available polyimide membrane (DuraMem) was 
also investigated to compare the performance of the lab-made membranes. The following 
conclusions are made, after all the experimental works: 
 Pre-crosslinking of a 2.5% PDMS (RTV 615) solution at 60oC with a viscosity of 
~45mPa-s served the as best method to prepare the thin active layer of a composite 
PDMS membrane. PDMS solutions with higher concentrations resulted in tighter 
membranes with little to no permeability. Moreover, a viscosity lower than ~45 
mPa-s reduced the permeability of the membranes. 
 
 The optimum condition of the composite PDMS (RTV 615) membranes for final 
cross-linking was 60oC in the oven for 4 hours. With an increase in cross-linking 
time in the oven, the membranes became tighter and the flux through the 
membranes decreased. 
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 SYLGARD 184 as a PDMS solution required longer cross-linking period (~18 
hours). The use of 10 g clip package from the supplier consisting of a pre-measured 
hardener and base (10:1) might cause the requirement of longer and inconsistent 
cross-linking. 
 
 Flux was measured through the membranes in a dead-end filtration system at 
different pressures: 5, 10, 20 and 30 bars and all of the membranes showed a 
linearity between flux and pressure; that means no compaction of membranes was 
observed within this pressure range. However, at 40 bar, the composite 
PTFE/PDMS (SYLGARD 184) showed a compaction and reduction in 
permeability. 
 
 Hydrodynamic permeability coefficient of water through the TFC membrane as 
well as that of a commercially available polyimide membrane, DuraMem, was also 
determined. 
 
 Comparing the permeability of all of the membranes, it was found that 2.5% 
PTFE/PDMS (RTV 615, ~45 mPa-s) showed the highest permeability. 
 
 All of the membranes were tested to check their efficiency for the removal of IBP, 
NPR and DCF. PTFE/PDMS (RTV 615) was able to remove 70% IBP, 65% NPR 
and 65% DCF.  The removal efficiency of PTFE/PDMS (SYLGARD 184) for IBP, 
NPR and DCF was 53%, 57% and 65% respectively. On the other hand, the TFC 
membrane was able to remove 60% IBP, 56% NPR and 66% DCF. Along with that, 
DuraMem was found able to successfully remove 49% IBP, 45% NPR and 58% 
DCF. Therefore, it was observed that composite PTFE/PDMS (RTV 615) showed 
the highest removal capacity for IBP, NPR and DCF.  
 
 Composite PDMS membranes prepared with both commercially available PTFE 
and laboratory made PSF base support did not show any major difference in 
permeability and pharmaceuticals removal efficiency. 
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 Since 2.5% PTFE/PDMS (RTV 615) showed the best performance among all other 
membranes, this membrane was solely tested to see its retention capacity for EE2 
and it was found that it removed ~95-97% of EE2. 
 
 The retention mechanism of pharmaceutical compounds by composite PDMS 
membranes is explained here through Hansen’s Solubility Parameter theory, 
comprised of solute-membrane affinity, solute solvent affinity and solvent-
membrane affinity. The absolute difference between the solubility parameters of 
two molecules explains the strength of attraction between them; the higher is the 
difference, the lower is the mutual strength. The removal of EE2 is explained 
through size exclusion mechanism. 
5.1 Contribution of Thesis 
OSNF has been established as an auspicious and high potential separation process 
in organic solvent permeation due to flexibility, ease of production and less energy 
requirement over the past decade [1-4]. However, in aqueous media, the use of this 
promising technology has not yet been practiced. The present study offers a new area of 
research on the application of OSNF membranes in removing trace organic contaminants 
from water. Several batches of OSNF membranes were prepared using two different types 
of polymers in this study to establish the reproducibility of the performance of the 
membranes (see Appendix). Comparison of the lab-prepared OSNF membranes with a 
commercial polyimide membrane shows slight superiority of the lab prepared membranes 
with respect to permeability and removal efficiency of trace contaminants from water. 
While the presence of EE2 in waterbodies is currently considered a threat to aquatic life, 
this novel technology has been shown in the present study to successfully remove this 
endocrine disrupting compound from water.  
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5.2 Future Recommendations 
In this research work, all the experiments were carried out with synthetic water to 
evaluate the performance of the OSNF membranes. Therefore, the next step would be to 
utilize wastewater samples to verify if it affects the performance. Moreover, the effect 
of fouling on transport of organic micro-pollutants needs to be studied. Since this work 
initiates the application of OSNF for the purpose of water treatment, further research would 
be required to explore its applicability to different types of solutes in water. In literature, 
till date, the mechanism of transport and separation phenomena for OSNF membranes are 
not well understood. Therefore, detailed research would be necessary to enhance the 
understanding of the mechanisms of transport of solutes through OSNF.  
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Appendix 
List of OSNF Membranes Prepared in this Study: 
Types of 
Polymers 
Solvent % of Polymers # of Batches # of 
Membranes 
RTV 615 Toluene 20% 2 10 
RTV 615 Toluene 15% 2 10 
RTV 615 Toluene 7.5% 2 10 
RTV 615 Toluene 5% 3 15 
RTV 615 Toluene 2.5% 5 25 
RTV 615 Toluene 1.85% 5 25 
RTV 615 Hexane 2.5% 2 10 
RTV 615 Hexane 1.85% 5 25 
SYLGARD 184 Hexane 20% 4 12 
SYLGARD 184 Hexane 15% 3 6 
SYLGARD 184 Hexane 12% 3 12 
SYLGARD 184 Hexane 10% 3 12 
SYLGARD 184 Hexane 7% 3 12 
SYLGARD 184 Hexane 5% 3 12 
SYLGARD 184 Hexane 3.1% 5 15 
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List of TFC Membranes Prepared in this Study: 
PSF MPD TMC MWCNT # of 
Batches 
# of 
Membranes 
20% - - - 10 50 
15% - - - 5 25 
20% 2% 0.1% - 4 20 
20% 2% 0.2% - 4 20 
20% 2% 0.1% 1% (modified) 2 6 
20% 2% 0.1% 0.5% (modified) 2 6 
20% 2% 0.1% 0.1% (modified) 2 6 
20% 2% 0.1% 0.5% (unmodified) 2 6 
20% 2% 0.1% 0.1% (unmodified) 2 6 
20% 2% 0.1% 1% (unmodified) 2 6 
 
 
 
SYLGARD 184 Hexane 2% 5 15 
SYLGARD 184 Hexane 1% 5 15 
SYLGARD 184 Hexane 0.5% 1 2 
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